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CHAPTER 1
General Introduction
8An important goal in biology is to understand life at the molecular level, to understand how 
cells and organisms are built from complex mechanisms involving DNA, proteins and other 
molecules, and how these mechanisms dysfunction to cause disease. The complexity of these 
mechanisms is enormous. For example, the human genome contains roughly three billion 
base pairs [1] and encodes for more than twenty-nine thousand proteins [2]. Extra dimen-
sions to these numbers are added by the presence of different protein states and abundance 
which vary over time and cellular localization, and in turn depend on interactions with DNA, 
other proteins, molecules and environmental factors. Decades of research in this area have led 
to a vast base of knowledge about these complex systems. However, this knowledge probably 
merely scratches the surface of the underlying complexity and we are still unable to com-
pletely understand complex, multifactorial diseases, let alone to predict the effects of a novel 
drug to cure these diseases.
Biological pathways are often used to abstract and modularize our knowledge about molecu-
lar biology. A pathway organizes our knowledge with respect to a functional mechanism and 
describes events at the molecular level that compose this mechanism. For example, the steps 
by which the molecular machinery in a cell operates to replicate DNA [3], control the cell 
division [3], or degrade glucose to produce energy [4] may each be represented as a pathway. 
A pathway typically describes a set of molecular entities, their relations and interactions, and 
how they vary in spatial dimensions within a given context. For example, a basic version of 
the intrinsic apoptosis pathway would describe the following events [3]:
•	 Cytochrome-c is released from the mitochondria and binds to Apaf-1
•	 Apaf-1 molecules bound to Cytochrome-c aggregate and bind to Procaspase-9
•	 Procaspase-9 is cleaved into activated Caspase-9
•	 Caspase-9 in turn cleaves other proteins from the Caspase family, initiating a cascade
•	 These Caspases in turn cleave several proteins to set in motion the dismantling of the cell
Grouping these relations and events in a pathway summarizes our knowledge about genes, 
proteins and other molecules at a functional level. Although the boundaries of a pathway are 
strictly taken arbitrary, a set of canonical pathways has evolved over the years, comprising 
many generic mechanisms in the cell [5-7].
Pathways are a powerful visual aid when represented as a diagram [8,9]. For example, the 
apoptosis example from the previous paragraph can be depicted as the diagram shown in 
Figure 1A, which gives an overview of the order of events, participants and their relations in 
a single image that is relatively fast and easy to comprehend. In this case, the depicted mecha-
nism is relatively small and simplified, but depending on the goal of the diagram, a pathway 
diagram can be made more detailed. For example, Gerhard Michal created an extensive meta-
bolic pathway diagram often referred to as the Boehringer-Mannheim biochemical pathways 
chart (Figure 1B), covering over 700 enzymes and their reactants [10]. Although harder to 
interpret, such a complex diagram is still a powerful complement to textual representations 
of the knowledge it represents. Indeed, Michal’s metabolic map is printed as wall chart and 
hangs above many a researcher’s desk as reference. The diagram makes it possible to track dif-
ferent paths from one metabolite to another, which would otherwise require looking up bits 
of information dispersed over textbooks or journal publications. Along the same line, the dia-
gram makes it easier to lookup the involvement of a single enzyme in conversion of different 
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metabolites. In addition, when looking at the diagram from a distance, general structures 
become visible (such as the cyclic form of the TCA cycle) and bottlenecks or focal entities are 
easier to spot. Therefore, pathway diagrams facilitate comprehending the overall structure of a 
biological mechanism and predicting possible implications of perturbations (e.g. when one of 
the proteins is mutated in a disease or targeted by a drug), thereby providing a stepping stone 
for further research based on existing knowledge.
In the last decades, the amount of data that researchers in biology can measure experimen-
tally has greatly increased thanks to the development of high-throughput experimental tech-
niques. These so-called ‘omics’ experiments measure tens of thousands of entities in parallel, 
allowing to study for example gene expression [11], protein or metabolite abundance [12] 
in many different biological samples. In addition, functional data can be measured directly 
at a large scale, such as protein interactions [13] and protein-DNA binding [14]. The large 
Figure 1: Two examples of a pathway diagram, differing in detail and visual style. A: The intrinsic apoptosis pathway, adapted from 
[3]. B: The metabolic pathway map created by Gerhard Michal.
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coverage and relatively high noise level in the data gathered by these techniques make them 
especially useful for exploratory analyses, to identify relevant biological mechanisms and gen-
erate hypotheses. These hypotheses can then be targeted with smaller scale, but more sensi-
tive experiments. This approach improves our ability to research multifactorial diseases or 
phenotypes, where the molecular basis does not limit to a single gene, process or tissue. The 
sheer size of these datasets makes it practically impossible to manually comprehend them and 
understand the underlying biology, which calls for bioinformatics approaches to assist the 
human mind.
A critical step in the analysis of a dataset is to integrate it with existing knowledge. Even when 
the dimensionality of the data has been reduced with data-driven methods such as clustering 
or pattern recognition, the size and complexity of our knowledge make it hard to manually fit 
these results into what we already know. For example, MEDLINE, the database for scientific 
literature in the life sciences field contains over 20 million articles as of 2010 and shows a 
continuously increasing growth [15]. Typically, all this knowledge is not readily available in 
a researcher’s mind, which often results in focusing on small groups of proteins or a single 
mechanism that is suspected to play a role, or that is within the field of expertise of the re-
searcher. Unfortunately, that approach does not exploit the key feature of high-throughput 
techniques (their ability to measure a large diversity of entities) and stands in the way of a 
more holistic view of molecular biology. Therefore bioinformatics methods may be necessary 
in this step of the analysis as well, for example to integrate, summarize and present the data in 
context of biological knowledge. Biological pathways could provide a powerful medium for 
utilizing existing knowledge in bioinformatics approaches for exploratory data analysis. They 
are already an abstraction of our knowledge that is more amenable to computing than purely 
textual information. Furthermore, pathway diagrams provide a way to combine biological 
knowledge with data visualization to aid human interpretation of the results.
This thesis focuses on applying the concept of biological pathways to bioinformatics ap-
proaches in exploratory data analysis. The main goal of this thesis is to improve data analysis 
by utilizing existing knowledge in the form of biological pathways. Chapter 2 summarizes 
work that has already been done in this area and discusses several guidelines and prerequisites 
for utilizing pathways in exploratory data analysis.
One requirement for applying pathways in bioinformatics research is the availability of com-
putable versions of biological pathways that can be kept up-to-date with the latest knowledge. 
Archiving and curating available literature as pathways is an immense task, requiring exper-
tise from researchers across the world and is therefore especially challenging [16]. Chapter 3 
describes a novel platform for collecting, curating and sharing knowledge as biological path-
ways in a digital form, which applies a community-based approach [17] where the research 
community is directly engaged in improving pathway information.
A key aspect of exploratory data analysis is to look at the data from different points of view, 
which requires different bioinformatics software, resources and workflows. To optimally inte-
grate pathways in these tools, the pathway information needs to be accessible programmati-
cally. Furthermore, pathway information evolves as our knowledge grows, requiring these 
tools to use up-to-date information. Chapter 4 describes a web interface that improves pro-
grammatic access to pathways and integration in existing and future bioinformatics tools and 
analysis workflows.
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Multifactorial diseases and phenotypes typically do not result from a single mechanism, but 
result from interplay between different pathways. Therefore, to improve understanding of a 
dataset based on a complex disease, we need to look beyond pathway boundaries at inter-
actions between pathways. Chapter 5 applies an exploratory data analysis approach to find 
interactions between pathways in the context of obesity and insulin resistance. This analysis 
demonstrates that combining different bioinformatics tools and integrating pathways with 
additional information, such as protein interactions, provides new perspectives on an experi-
mental dataset and improves our ability to generate new hypotheses.
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CHAPTER 2
Finding The Right Questions:
Exploratory Pathway Analysis To 
Enhance Biological Discovery In Large 
Datasets
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At a time when biological data are increasingly digital and thus amenable to computationally 
driven statistical analysis, it is easy to lose sight of the important role of data exploration. Suc-
cinctly defined over 30 years ago by John Tukey [1,2], exploratory data analysis is an approach 
to data analysis that focuses on finding the right question, rather than the right answer. In 
contrast to confirmatory analysis, which involves testing preconceived hypotheses, explor-
atory data analysis involves a broad investigation, a key component of which may be visual 
display. Though his arguments predate personal computing and thus focus on graph paper 
and ink, the point still stands: good data visualization leads to simpler (better) descriptions 
and underlying fundamental concepts. Today, there is tremendous potential for computation-
al biologists, bioinformaticians, and related software developers to shape and direct scientific 
discovery by designing data visualization tools that facilitate exploratory analysis and fuel the 
cycle of ideas and experiments that gets refined into well-formed hypotheses, robust analyses, 
and confident results.
Pathways for Exploratory Data Analysis
A rich source of visual material relevant to the study of biology is pathway diagrams. Path-
ways map our understanding about connections and processes underlying biological func-
tion. They are powerful models for exploring, interpreting, and analyzing biological datasets 
and provide a medium to apply Tukey’s exploratory data analysis principles to the present-day 
study of biology (Figure 1). Pathways organize and visualize data and provide a model that 
both computers and humans can work with, since they are abstract enough to allow for semi-
automatic integration and querying in a biological context, and biologists are by and large 
familiar with pathway diagrams. Ongoing efforts to capture biological knowledge in pathway 
databases [3] and data exchange formats [4] demonstrate growing interest in applying path-
way visualization and analysis to biology research.
Currently, several bioinformatics 
tools provide pathway visualization 
to support the exploration of data-
sets [5,6]. DeRisi et al. projected the 
changes in mRNA expression on the 
carbon and energy metabolism path-
way to create a visual representation 
of the properties of metabolic repro-
gramming during the diauxic shift 
of yeast [7]. Bensellam et al. applied 
similar visualization techniques to 
connect beta cell physiology to spe-
cific metabolic and signaling path-
ways in rat islet cells [8]. A pathway 
also incorporates a collection or set 
of biological entities (e.g., genes, pro-
teins, metabolites) that function in 
the biological process described by 
the pathway. This information can be 
used to reduce the dimensionality of 
Figure 1: Pathways for exploratory data analysis. Biological pathways are 
powerful visualization tools for data exploration, focused on finding the 
right question.
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large datasets. Identifying pathways that are overrepresented with entities showing interest-
ing behavior gives an overview of global patterns among different biological processes. Many 
tools and techniques implement this principle [6,9], and it has become an integral part of 
gene expression data analysis [10]. Recent innovations utilize connectivity and weighting in 
the calculation of pathway impact [11]. These techniques produce a list of putatively affected 
pathways that serves as a basis for researchers to develop testable hypotheses of mechanism 
or direct further exploration. Importantly, when pathway representations are employed in ex-
ploratory data analysis, the goal is not a statistical solution, but rather an investigation of the 
scope of the data and relevant patterns. Pathways serve as the medium for communication, 
in which the biological story is extracted from the data, prior knowledge is integrated and 
understanding is constructed [12]. 
Challenge
An important goal of “-omics” experiments is to generate directed hypotheses based on rela-
tively noisy but large-scale datasets, which can then be tested in targeted experiments. In this 
respect, exploratory and confirmatory approaches are complementary, where applying ex-
ploratory techniques is a logical first step in the analysis [2]. The relationship is actually more 
iterative than sequential, where a certain level of statistical analysis or reduction might be 
required before applying an exploratory technique. But in the overall trajectory from explor-
atory to confirmatory, exploration is most important in forming a conclusive statistical ap-
proach. In the field of pathway analysis, there is active research in developing new techniques 
and tools from the confirmatory paradigm, using pathways to improve statistical power on 
specific hypotheses [9,11,13–16]. The value of these techniques for exploratory analysis, how-
ever, is limited in the absence of a comprehensive framework for exploration and visualiza-
tion. The challenge we face now is to fill this gap and to develop flexible tools and pathway 
content based on the exploratory data analysis paradigm.
Looking at hallmarks of exploratory data analysis may suggest ways that pathways can be 
more effectively used in data exploration. We will discuss three properties that typify both 
the exploratory technique and analyst: flexibility, interactivity, and effectiveness. By relating 
properties of exploratory data analysis to the current state of pathway analysis techniques, 
we hope to guide researchers in how to best utilize pathway information in exploratory data 
analysis and help focus future tool development towards better exploratory pathway analysis 
techniques.
Flexibility
Exploratory analysis is not a linear start to end process with fixed analysis steps but requires 
flexibility from both researchers and tools. The decision on what will be the next step in an 
exploratory analysis is guided by the data and observations rather than by a predefined plan, 
as is the choice for the technique that is most suitable for highlighting the features under 
investigation. In exploratory data analysis, we look at the data from many different points of 
view, few of which actually lead to new or relevant observations. But knowing that a certain 
description of the data does not lead to a new or relevant observation is itself a step forward 
in the analysis. The following analogy from Tukey illustrates this: 
“As detective stories remind us, many of the circumstances surrounding a crime are 
16
accidental or misleading. Equally, many indications to be discerned in bodies of data 
are accidental or misleading. To accept all appearances as conclusive would be de-
structively foolish, either in crime detection or in data analysis. To fail to collect all 
appearances because some—or even most—are only accidents would, however, be 
gross misfeasance…” [1].
Thus, open-mindedness is important when using pathways for exploratory data analysis and 
provides software developers with both a challenge and an opportunity. It is hard to create 
versatile software that does not restrict researchers to a single workflow. A more generic, flex-
ible framework to support various pathway analysis procedures would be very powerful and 
would provide a basis for developing new and better pathway analysis techniques. Therefore, 
instead of aiming for a single, isolated software package, developers should implement flex-
ible solutions that can be integrated in a larger toolbox for pathway analysis, in which each 
tool provides a different perspective on the dataset. In turn, rather than depending on a single 
program or algorithm to produce a publishable statistic, biologists should seek tools that help 
comprehend the data, view it from different angles, and thereby lead to greater understanding 
of what’s going on.
Consider canonical pathways. These pathways summarize complex biological processes in 
a comprehensible way, however, these summaries may omit important details by grouping 
entities, leaving out alternative routes, and imposing artificial boundaries. By limiting analysis 
to canonical pathways, a researcher is less flexible, fixated on well-described knowledge, and 
blind to less certain, but potentially more interesting clues. Reality is much more complex 
than what is depicted in the typical canonical pathway, as has been demonstrated by avail-
able protein–protein interaction networks [17] and curated interaction databases, such as 
Reactome [18]. However, visualizing every possible interaction or entity that might contrib-
ute to a process can lead to large incomprehensible “hairball” networks that do not facilitate 
exploratory analysis. How can we optimally use both types of information in an exploratory 
analysis? 
One option might be to consider canonical pathways as a starting point in the analysis, based 
on solid foundations from which we might explore less known but potentially interesting 
areas. For example, a pathway could be dynamically extended with interactions from other 
pathways, protein–protein interactions, or relations from literature, based on a set of entities 
that show interesting behavior in the dataset under investigation. In that way, the researcher 
can explore instances or interactions that might not be integral to the canonical pathway, 
but might still be relevant to the observations in the pathway. This process could become 
data-driven, by highlighting and filtering information that is potentially interesting based on 
the experimental data and context, instead of showing all available information. An analysis 
environment that exploits both canonical pathways and detailed interaction networks would 
encourage researchers to take a flexible, exploratory attitude and facilitate construction of an 
understandable biological story from complex data.
For developers, realizing that exploratory pathway analysis tools might be used not only in 
isolation but also with other software and different types of data in a flexible analysis setup 
might guide software design and implementation. For example, providing an application 
programming interface (API) in addition to the user interface greatly enhances the flexibil-
ity to adapt a tool for customized analyses or to reuse components. Reusability of software 
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components that perform common tasks and define general data models leads to more unity 
among pathway analysis tools. For example, a data format will be more easily adopted by 
other developers when an API is available to read, modify and write it. In addition, providing 
an API opens up the possibility for scripting to automate tasks and combine functionalities of 
different tools. This introduces a nearly unlimited flexibility and allows a developer to focus 
on the main functions of a tool and keep the user interface simple and focused, while keeping 
the option open for advanced users to automate and combine standard features of different 
tools to perform a novel type of analysis.
Interactivity
An exploratory analysis is not an automatic process, but relies on decisions by the researcher. 
Where calculation or visualization tasks may fall to the computer, the researcher controls 
interpretation and decisions on what data should be viewed, from which angle and in which 
context. Graphical representations of data are important. As Tukey notes, a good visualization 
“forces us to notice what we never expected to see,” and “The graph paper (or visualization 
software) is there, not as a technique, but rather as recognition that the picture-examining eye 
is the best finder we have of the wholly unanticipated” [2]. Interactive graphics allow the re-
searcher to take control of how the data are visualized and stimulates the researcher to change 
the visualization perspective based on previous observations.
Pathway analysis techniques that allow the researcher to explore data interactively (rather 
than delivering a static view) will facilitate exploration and increase the chance of finding in-
teresting observations or patterns. There are several opportunities to improve interactivity of 
pathway visualizations and highlight features relevant to the question being asked while, just 
as importantly, filtering out irrelevant features.
Geographical maps illustrate the advantages of interactivity provided by effective visualiza-
tion software. Paper maps divide the world into multiple views of fixed scope and scale. You 
can look at a map of the complete world with limited detail or a city map without context. 
But paper maps are cumbersome and lack critical interactivity (folding a map doesn’t count). 
Digital maps, on the other hand, have several advantages, such as the ability to switch scale 
through interactive zooming, so you can scroll the viewport to trace a possible route or track 
your real-time location with GPS information. The integration of information, in general, is 
yet another advantage, as you can add and remove layers of information on the same map. 
Such integrated information can be interactively queried to find a particular intersection, a 
high concentration of public parks, or the best route through traffic. The parallels to biological 
pathways are obvious and should be exploited at every opportunity in the design of pathway 
analysis tools. The example of traffic overlays even hints at the dynamics of biological pro-
cesses, e.g., the flow of biochemistry through metabolic pathways. 
Developers of exploratory pathway analysis tools could borrow concepts from the analogy 
with geographical maps. For example, enrichment analysis techniques group genes, proteins, 
and metabolites at the level of pathways ranked by activity. This provides a global “world 
map” view, showing which pathways may be affected while discarding information about the 
inner workings of these pathways. This scale may hold information on how each pathway 
acts as a unit in a specific context and how these units relate to each other. Such relationships 
could include child–parent relations (glucose metabolism and fatty acid metabolism are both 
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metabolic pathways), the flow of substances (the output of glycolysis is an input for the TCA 
cycle) or causal relations (the P53 pathway regulates apoptosis). In contrast to the global scale, 
techniques based on the constituents of pathways provide a more mechanistic “city map” view 
by relating data to localized interactions and reactions. Continuing to zoom to the molecular 
level reveals protein domains, the exon structure of splice variants, and polymorphisms. In-
teractivity may be improved by allowing seamless transitions between these scales by utilizing 
semantic zooming [19], where the displayed features and level of detail change automatically 
along with the zoom level and context. Given that most analysis tools focus on pathway in-
formation at a single scale, switching between these scales within an exploratory analysis is 
far from trivial.
Effectiveness
The interactive, user-directed character of exploratory data analysis imposes stricter crite-
ria on the effectiveness of exploratory techniques. The techniques described in Tukey’s text-
book on exploratory data analysis are surprisingly simple and easy to apply merely with paper 
and pencil. This allows the researcher to take a quick look at typical questions—“could it be 
that…?” or “what if it is the case that…?”—without investing days of work on that single 
question. Effective techniques that are relatively easy to apply and work in a transparent way 
encourage the researcher to take a true exploratory attitude instead of following well-trod 
paths while ignoring side roads that may reveal unexpected but interesting aspects of the data.
Of course, if the chance of finding an interesting observation in the data does not outweigh 
the efforts to perform an analysis technique, researchers may decide not to use the technique. 
This problem may be less relevant in confirmatory approaches, where investing a large effort 
in a single technique is often justified because the effort versus results can be weighed dur-
ing planning. However, in exploratory analysis, a single technique is only a small part of the 
whole analysis (many clues need to be considered, with different techniques), and the yield is 
often unpredictable (many clues lead to dead ends). Therefore, the acceptable maximum ef-
fort is very low, and to make pathway analysis techniques suitable for true exploratory analy-
sis, this should be taken into account.
Unfortunately, many obstacles and annoyances exist when applying current pathway analy-
sis techniques. While modern computers allow fast data processing and visualization, there 
remain numerous hurdles beyond the need to install and train on multiple software pack-
ages and the need to format and reformat datasets into specific input formats. Reordering 
data columns might not be a major hurdle—spreadsheet software that performs this task is 
widely available. But mapping data to different identifier systems or applying calculations on 
the data is less trivial and more prone to error, often requiring specific bioinformatics skills. 
Pathway analysis tools should aim to remove the responsibility of data reformatting from the 
researcher by making tools more flexible to different types of input data or to adhere to widely 
adopted standards. Generic libraries and services that might assist the developer in this task 
are already available, such as BridgeDb [20] for identifier mapping (to support multiple iden-
tifier systems), Web services to access the latest pathway information [21–24], or paxtools 
[25] for reading pathways in the BioPAX standard.
The pathways themselves require library-like organization and curation. A handful of proj-
ects have undertaken the task of capturing and curating this knowledge as semantic content 
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that is amenable to computation [18,21,26–28]. Unlike systems biology networks, pathways 
cannot be directly inferred from high-throughput data, but rather require the synthesis of 
multiple discoveries, insights, and diverse data types spanning years, or even decades, of work 
by multiple groups, offering an opportunity for tool developers to facilitate the entry, cura-
tion, and distribution of pathway content in effective formats [4,28,29]. BioPAX and SBGN 
are particular examples of community-driven formats for pathway semantics and graphical 
notation, respectively. Pathways should be understandable by researchers who may not be 
fully familiar with the biological process that is described, enabling researchers to look at data 
in context of knowledge outside the scope of their specialty [5]. The most effective pathways 
are self-explanatory, contain detailed information about biological context, and reference rel-
evant primary data sources and literature.
Another opportunity to make exploratory pathway analysis techniques more effective is to 
work on better integration with public data resources. Biologists create a wealth of data, which 
is often available in a public repository, such as ArrayExpress or GEO for transcriptomics 
datasets [30,31]. During an exploratory analysis, it can be valuable to extend beyond the re-
searcher’s own data to consider relevant orthogonal or correlated datasets. However, this is 
an inefficient process. The researcher must manually find the right datasets, download the 
data files from the repository, reformat the data, and import it in the pathway analysis tool. 
An increasing number of public repositories support Web service queries, assisting develop-
ers in building tools that perform these tasks programmatically [32]. Repositories and tools 
that expose data and methods through Web services can readily be integrated into effective, 
reusable workflows in pathway analysis tools, leading to high-order standards in data analysis.
Effective data integration is a significant hurdle in working with different datasets and path-
ways in exploratory analysis. Determining what to integrate and how to present it to the user 
depends on the context and the question being asked. However, this context is typically de-
fined at the semantic level and, thus, is hard for computers to work with. For example, a com-
puter can easily handle the command “hide everything above a certain p-value threshold,” but 
has trouble with “show me all data related to cancer.” In an ideal situation, the data are anno-
tated with this information, but the computer still needs to deal with synonyms or subtypes of 
the word “cancer.” It becomes even more complex when integrating data at the pathway level, 
where the researcher could ask something like “show me all studies in which MYC is activated 
by MAPK.” Such questions require correctly annotated pathway information and must deal 
with information at the semantic level (which interactions “activate”) and synonym or identi-
fier mapping problems (which entities map to “MAPK”). 
Recent developments begin to address these issues. Ontologies help in dealing with informa-
tion at the semantic level. For example, a disease ontology could tell the computer that mela-
noma is a subtype of cancer, and an event ontology could tell the computer that activation 
could include phosphorylation, translation or receptor binding interactions. Standards for 
ontologies, such as the OBO format, and resources that provide access to different ontolo-
gies through unified Web services [33] provide the necessary interfaces for tool developers 
to improve integration of different types of data in pathway analysis tools. In addition, data 
repositories are actively working on annotating raw datasets to provide better context [34,35], 
ready to be queried by pathway analysis tools through Web interfaces. Sometimes referred to 
as integromics, or multi-omics, the integration of annotations and data is critical to extracting 
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the full potential from large and high-throughput datasets [9,36,37]. Effective construction, 
analysis and visualization of multi-omic datasets depend on innovative software. These tools 
must understand what is going in (i.e., with the help of ontologies and data exchange stan-
dards), know how to merge and normalize across orthogonal data types, and be adept at 
displaying multi-dimensional information in meaningful and intuitive contexts. This is a par-
ticularly ripe area for exploratory tool developers.
Conclusion
Biological pathways are a powerful medium in the exploratory analysis of biological datasets, 
providing a conceptual framework that is familiar to biologists, visually oriented and increas-
ingly available in digital formats that allow interactive display and analysis. By discussing 
properties of exploratory data analysis in the light of pathways, we highlighted several op-
portunities for researchers and developers to use pathway analysis in an exploratory setting. 
Rather than trying to provide a complete overview of pathway analysis approaches, we dis-
cussed several ideas and recent developments that lay out a path towards a powerful set of 
pathway analysis tools developed from an exploratory analysis paradigm. A critical recurring 
issue is that current pathway analysis tools are rather isolated and hard to combine within an 
analysis. This may discourage researchers to follow clues that require the use of a different tool 
to view the data from another perspective, thereby standing in the way of a true exploratory 
attitude. The field of exploratory pathway analysis is still in its beginning, but with focused 
and coordinated development, it may eventually play an important role in providing the right 
questions for confirmatory approaches.
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CHAPTER 3
WikiPathways:
Pathway Editing For The People
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The exponential growth of diverse types of biological data presents the research community 
with an unprecedented challenge and opportunity. The challenge is to stay afloat in the flood 
of biological data, keeping it as accessible, up-to-date, and integrated as possible. The oppor-
tunity is to cultivate new models of data curation and exchange that take advantage of direct 
participation by a greater portion of the community.
This combination of challenge and opportunity is especially relevant to the task of collect-
ing biological pathway information. Pathways are critical to understanding the functions of 
individual genes and proteins in terms of systems and processes that contribute to normal 
physiology and to disease. Each biological pathway must be hewn from a mass of biological 
information distributed across multiple publications and databases.
The particular challenge of pathway curation is amplified, because pathways are often pre-
sented as static images that are not amenable to computation, integration, or data exchange. 
Furthermore, pathway experts are distributed throughout the world, and most have limited 
time to learn about complex databases that need their expertise. This challenge can be met 
by taking the opportunity to develop a new community-based model for pathway curation.
One way to engage the community is with a wiki model, as exemplified by Wikipedia [1]. 
We see the potential for a wiki-based pathway curation resource, coupled with an embed-
ded graphical pathway editing tool, to meet the growing challenge presented by the influx 
of biological data and to provide an innovative example of content curation by the biology 
community (Figure 1).
Facing the Challenge
The research community is experiencing massive growth in biological data, from genome and 
metagenome sequencing to high-throughput assays and microarray studies. This growth has 
created a need for models of data storage and distribution that support a continuous stream 
of end-user submissions, frequent updates, integrated search across databases, and access to 
data formats (preferably community standards) that are amenable to computational analyses. 
By and large, the need is being met for certain types of biological data: sequences go to Gen-
Bank and European Molecular Biology Laboratory (EMBL)-Bank, protein structures go to 
the Protein Data Bank (PDB), and microarray results go to Gene Expression Omnibus (GEO) 
and ArrayExpress. But as the influx and complexity of biological data continues to grow, so 
will the challenge of organizing and maintaining these databases.
Fortunately, the biology community can provide an answer that will scale with the challenge: 
community curation. There is a growing tendency toward information exchange that supports 
open access, higher-order organization, community-defined data formats, and collaborative 
online environments. This trend is most apparent with the growing number of open-access 
journals (see the Directory of Open Access Journals at http://www.doaj.org/), public data-
bases [2], and data exchange formats [3] and ontologies [4]. To promote community curation, 
database maintainers must be willing to relinquish some control. After removing logistical as 
well as technical barriers with creative support tools, the data producer will also be the data 
organizer. Despite initial misgivings, such projects do succeed with the right balance of infra-
structure, participation, and administrative principles, as demonstrated by Wikipedia [1], nu-
merous open-source software projects (e.g., Linux, Apache, MySQL, Firefox), and countless 
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scientific collaborations, including the Internet, itself.  The idea of using wiki technology for 
biological information has been proposed in other areas, for example, genome annotation 
[5,6]. The EcoliWiki provides a working example of community curation focused on Esch-
erichia coli (EcoliWiki, http://ecoliwiki.net). And WikiProteins aims to combine automated 
text mining with community curation to annotate biomedical concepts, including protein 
functions, interactions, and disease relationships [7]. 
Representing Biological Pathways
Biological pathways present a special case in which the information is not directly coupled to 
data collection. One does not sequence or measure a pathway. Pathways comprise a myriad of 
interactions, reactions, and regulations, which are often identified piecemeal over extended 
periods and by a variety of researchers. As a result, pathway information is particularly 
challenging to compile and curate. Furthermore, biological pathways are often captured only 
as static images for publications or presentations. Consider the pathway illustrations common 
in textbooks and review articles that document any given field of biology. A typical signal-
ing pathway, for example, represents receptor-binding events, protein complexes, phosphory-
lation reactions, translocations, and transcriptional regulation, with only a minimal set of 
symbols, lines, and arrows. While these simple images are powerful visual and conceptual 
representations, they cannot be connected to relevant biological annotations or analyzed with 
respect to experimental data. 
Figure 1: Two Models for Managing Biological Data. Current biological databases provide the community with data submission 
forms or tools and access to the compiled data via websites, FTP sites, and, sometimes, programmatic interfaces (API). Internal 
curation teams organize and update the data. A wiki model for biological databases, such as WikiPathways, provides a single, 
intuitive interface for submitting, updating, organizing, and accessing data, allowing the community to participate in the curation 
process and keep up with the influx of new data. The widths of the arrows represent the relative capacity for data management in 
the two models.
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A number of groups have taken on the challenge of curating and archiving biological path-
ways [8]. Those efforts mainly rely on internally supported teams of biologists or contracts 
with volunteer experts in particular fields of biology. Their curation tools typically require 
download, installation, and specialized training and are not designed for broad or collabora-
tive use. Often, the barrier is simply too high for the average biologist to consider contribut-
ing their own pathway knowledge. Even when it is contributed, pathway information can 
remain untouched for years in the current databases, quickly becoming outdated and out of 
sync with the continuing stream of published discoveries. Some of us (BRC, KH, ARP) have 
first-hand experience with maintaining the GenMAPP [9] pathway archive in this fashion 
over the past 8 years. The task of submitting and updating content inevitably falls on a handful 
of specialists who have invested significant time installing and learning how to use the cura-
tion tools. This approach is not sustainable in the face of the growing influx of biological data. 
Clearly, curating all of biology is a Herculean task for any single group.
Pathway Editing for the People
To facilitate the contribution and maintenance of pathway information by the biology com-
munity, we established WikiPathways (http://www.wikipathways.org). WikiPathways is an 
open, collaborative platform dedicated to the curation of biological pathways. WikiPathways 
thus presents a new model for pathway databases that enhances and complements ongo-
ing efforts (see Kyoto Encyclopedia of Genes and Genomes (KEGG) at http://www.genome.
jp/kegg, Pathway Commons at http://www.pathwaycommons.org/pc/, and [10]) . Building 
on the same MediaWiki open-source software that powers Wikipedia, we added a custom 
graphical pathway editing tool and integrated databases covering major gene, protein, and 
small-molecule systems. The familiar web-based format of WikiPathways greatly reduces the 
barrier that prevents participation in pathway curation. More importantly, the open, public 
approach of WikiPathways allows for broader participation by the entire community, ranging 
from students to senior experts in each field.  This approach also shifts the bulk of peer review, 
editorial curation, and maintenance to the community. 
Each pathway at WikiPathways has a dedicated wiki page, displaying the current diagram, 
description, references, version history, and component gene, protein, and metabolite lists 
(Figure 2). Any pathway can be edited from within its wiki page by activating an embedded 
pathway editor. WikiPathways uses an applet version of PathVisio—a pathway-drawing tool 
we developed for pathway curation (see PathVisio at http://www.pathvisio.org and unpub-
lished data). PathVisio provides a basic palette of objects and annotations needed to represent 
biological processes. Gene, protein, and metabolite objects directly map to biological anno-
tations from multiple public databases through an extensible identifier synonym database 
maintained at WikiPathways. The editing tool facilitates annotation with keyword search 
and auto-completion. Relationships between entities can easily be drawn using “smart con-
nectors” that snap into place. Lines can even connect to other lines to intuitively represent 
catalysis or other mediated processes. Entities can be grouped to represent complexes and 
related collections of genes. The editing tool also makes it easy to annotate these entities and 
relationships with peer-reviewed literature references. The “Help” section of WikiPathways 
provides guidelines and tutorials for how to use the editor and how to best represent path-
way information, as well as how to download and use the pathways in GenMAPP analyses. 
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After editing, an updated pathway image is displayed on the wiki page along with the ver-
sion history and list of components. Users can easily monitor and undo changes, compare 
differences, and search for overlapping pathways. Any registered user can add a pathway to 
their “watch list” so that they receive email when the pathway is changed.  All changes can be 
reversed, restoring the pathway to an earlier version. Different versions of pathways can be 
compared side-by-side using an integrated difference–viewing tool, customized for graphical 
pathway information. Using the search feature, one can locate particular pathways by name, 
by the genes and proteins they contain, or by the text displayed in their descriptions and com-
ments. One can also browse the collection of pathways with combinations of species names 
and ontology-based categories. Currently, WikiPathways contains 537 species-specific path-
ways for human, mouse, rat, zebrafish, fruit fly, worm, and yeast. The mouse pathways, for 
example, contain 3,741 unique genes (~13% of the mouse genome). The pathway collection 
was nucleated with GenMAPP pathways, which were collected over the past decade from 
GenMAPP users. Now at WikiPathways, the collection is growing and improving through 
new contributions and curation, at an unprecedented rate, which we expect to dramatically 
increase as community participation grows.
Figure 2. Sample WikiPathways Page. Each pathway has a dedicated page for viewing and editing content. The pathway diagram 
is edited with an embedded applet version of PathVisio (inset). The Description and Bibliography sections can be edited in-page 
as well through applets that facilitate entry. Additional information about the pathway components and version history continue 
on the page (not shown).
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The pathway content at WikiPathways is freely available for download in a variety of data 
and image formats, including GenMAPP Pathway Markup Language (GPML), which is a 
custom XML format that is compatible with pathway visualization and analysis tools such 
as Cytoscape [11], GenMAPP [9], and PathVisio (http://www.pathvisio.org). GPML al-
lows researchers to draw and identify the molecular participants in a pathway, as well as the 
relationships among the participants. GPML is a work in progress, and though it does not 
yet have the full expressiveness of BioPAX (see the BioPAX Wiki at http://biopaxwiki.org/
cgi-bin/moin.cgi) or Systems Biology Markup Language (SBML) [12], it provides the basic 
functionality for researchers to create appealing pathway diagrams and to perform basic sta-
tistical tests on pathways such as overrepresentation analysis. The goal of GPML is to bridge 
the simple elegance of a pathway drawn on a napkin by a biologist (including its rich, human 
interpretability) and the growing databases of gene and protein annotations, interactions, and 
experimental data.  We prioritized the development of GPML based on what is already avail-
able and what is most useful to the average biologist: connecting intuitive, human-readable 
graphics to standardized identifiers from popular databases. This allows users to accurately 
label entities on pathways and computationally map them to experimental data using pathway 
analysis software. GPML also supports the representation of relationships between entities 
to allow network-based visualization and analysis. In a recent “community curation event” 
at WikiPathways, we formalized network relationships in the human pathway archive. We 
plan to include a number of BioPAX elements into GPML to support data exchange, but the 
overriding goal for GPML is to lower the barrier for contributors of pathway information by 
keeping it simple. This approach resonates with the large portion of the biology community 
interested in basic statistical pathway analyses and figures for publications and presentations. 
To assist pathway authors and curators, we are developing “bots” to survey the content and 
identify potential inconsistencies, redundancies, and incomplete data. The first of these bots 
identifies all the genes, proteins, and metabolites in any pathway that are not connected to a 
synonym database identifier. These reports along with additional curator tools will help con-
tributors to submit high-quality content and make corrections where needed. We also plan to 
use standard biomedical ontologies to structure the content of WikiPathways and to provide 
organization that can scale with rapidly growing and interrelated information.
Researchers interested in particular interactions or pathways can use WikiPathways as a re-
source for up-to-date pathway information and as a repository for their own findings that, in 
turn, are immediately available in multiple data formats for analysis as well as image formats 
for publication. WikiPathways can be used collaboratively to create, edit, and share pathway 
information with any colleague who has access to a Web browser. For sensitive content that is 
proprietary or must first be published as an original finding, pathways can be saved locally in 
the GPML format, ready to be uploaded and made public at a later time. Expert curators can 
use WikiPathways to monitor and update pathway information associated with their fields of 
interest. WikiPathways is also useful to students and professors of biology, providing path-
ways as educational materials and the editing history of a given pathway as an example of how 
scientific knowledge iteratively progresses.
To encourage participation by the community we have built templates for “User pages” and 
“Portals.” User pages help users identify themselves and their work, whereas Portals help en-
tire communities of users to identify themselves collectively and focus on particular pathway 
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domains, such as diabetes-related pathways or plant pathways. By using the template, users 
can build a site within WikiPathways dedicated to their lab, organization, or area of interest 
within minutes.  We are also organizing community curation events as a way to introduce new 
users to the curation tools and, at the same time, improve the quality of the pathway content. 
Future community curation events will focus on adding annotation, group representations, 
and literature references. 
Even prior to this publication introducing WikiPathways, we have seen strong signs of com-
munity participation. Outside of the immediate group of developers, WikiPathways has al-
ready attracted ten new mouse pathways, nine new human pathways, six new zebrafish path-
ways, three new rat pathways, and one Portal for the micro-nutrients community. There are 
dozens of E. coli and plant pathways currently being converted, and 3 new Portals under con-
struction. The site has over 220 registered users (10% contributing users) and has attracted 
developers through the Google Summer of Code program.
We envision WikiPathways being part of a broader effort to extend curation capacity to larger 
groups and communities.  This effort does not replace current approaches involving central-
ized teams of curators, but rather it complements and extends them. Eventually, we would like 
to see wiki solutions like WikiPathways used by current databases and curation sources.  Our 
future directions include supporting “reference” pathways contributed by other pathway data-
bases, and private workspaces for groups to collaboratively work on pathways before making 
them public. One could also imagine organizations installing local instances of WikiPathways 
for internal projects at research institutes or biotechnology companies. A journal, for exam-
ple, could host a version of WikiPathways that only contributing authors can edit. Where the 
same wiki technology is used, there are opportunities for seamless integration and controlled 
sharing of content when it is ready to be published or released to the public site. We will 
continue to work toward supporting broad implementations of WikiPathways to promote 
contributions from established and diverse sources.
WikiPathways is an experiment. We have considerable work ahead of us in developing the 
GPML data model, implementing critical features and, most importantly, building a commu-
nity of users and contributors. The success of WikiPathways will depend on the overall qual-
ity of its content, which will be a function of the infrastructure and administrative princi-
ples we use in addition to community participation. Features such as database connectivity, 
automatic consistency checks, curation tools, reversible edits, the visual difference viewer, 
and support by literature references will assist in tracking and reverting errant contribu-
tions, stimulating curation by the community. We anticipate that lowering the entry barrier 
for participation will allow for a greater capacity of curation, broader consensus on content, 
and ultimately, higher quality control. We are confident that WikiPathways will be a power-
ful resource for the research community and a vital forum for pathway curation. And we are 
hopeful that it will serve as an example for how the continuing flood of biological data can 
be managed and utilized by the community to irrigate future hypotheses and discoveries. 
Source Code
We are committed to open access and open source. All content is available under a Creative 
Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0/). All source code for 
WikiPathways and the PathVisio applet is available under the Apache License, Version 2.0 
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(http://www.apache.org/licenses/).  You can download the code from:
http://svn.bigcat.unimaas.nl/wikipathways
http://svn.bigcat.unimaas.nl/pathvisio
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Abstract
WikiPathways is a platform for creating, updating, and sharing biological pathways [1]. Path-
ways can be edited and downloaded using the wiki-style website. Here we present a SOAP 
web service that provides programmatic access to WikiPathways that is complementary to 
the website. We describe the functionality that this web service offers and discuss several use 
cases in detail. Exposing WikiPathways through a web service opens up new ways of utilizing 
pathway information and assisting the community curation process.
Introduction
WikiPathways is an online resource for biological pathway information and a platform for 
community-based curation [1]. Currently, WikiPathways contains more than 600 pathways, 
representing various species from bacteria and fungi to plants and animals. New species are 
being added on demand, and pathways are being created and edited almost daily. These path-
ways combine different types of biological knowledge, including protein interactions, meta-
bolic reactions, annotations from gene, protein and metabolite databases and references to 
scientific literature. Using a Java-based pathway editor, researchers can create, edit and an-
notate pathways directly on the website [2].
WikiPathways is accessed by the biology community mainly via a wiki-style website. In addi-
tion to the website, we recently implemented a web service that provides programmatic access 
to WikiPathways (figure 1). This makes it easier to integrate biological pathways in existing 
Figure 1: WikiPathways can be accessed by end-users from the wiki-style website. In addition, the WikiPathways web service 
provides a programmatic interface that can be used in many programming languages, including R, python, Java and perl and in 
workflow tools such as Taverna. Using this interface, new pathway analysis tools can be built and existing bioinformatics tools can 
be extended with pathway-based functionality.
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applications and provides a framework for pathway-centered analysis of experimental data. 
In contrast to other pathway resources with managed curation teams (e.g., KEGG [3] and 
Reactome [4]) or focused on distributing and querying pathway information (e.g., Pathway 
Commons [5]), WikiPathways is a primary source for richly annotated pathway content open 
to community curation. With the addition of web services, users have expanded access and 
advanced methods that uniquely apply to WikiPathways content. In this article, we discuss 
the web service functionality in more detail and highlight several use cases. 
Supplementary data, including full documentation, example client implementations, and 
source code, are available at http://www.wikipathways.org/webservice. The source code of the 
web service and all examples are licensed under the Apache 2.0 open-source license.
Results and Discussion
Web service functionality
The web service provides an interface to WikiPathways that can be accessed through the 
Simple Object Access protocol (SOAP), and the data structure and available functions are de-
scribed in the Web Service Description Language (WSDL). Both SOAP and WSDL are widely 
supported standards. The web service provides access to all pathway information on WikiPa-
thways in several different forms. Complete pathways can be downloaded in XML format 
(GPML) or a plain text file listing the biological entities and their identifiers. Image versions 
of a pathway can be retrieved in several graphics formats, including rasterized formats (e.g., 
Portable Network Graphics (PNG)) and vector graphics formats (e.g., Scalable Vector Graph-
ics (SVG) and Portable Document Format (PDF)). Additionally, color information can be 
specified to highlight specific elements of the pathway (e.g., to color protein entities accord-
ing to their measured expression). Individual interactions between biological entities that 
are defined in the pathways can be retrieved separately. Furthermore, information related 
to community-based curation, such as revision history and recently edited pathways, can be 
queried. A full list of available functions can be found in the supplementary data.
An index of all pathways is maintained using the Apache Lucene library [6]. This feature 
makes it possible to perform advanced search queries through the web service. All textual in-
formation on the pathway is included in the index to allow for keyword searches. In addition, 
the index uses synonym databases [2] to cross-reference between various biological databases 
and the entities on the pathways. This allows for queries to find all pathways for any given bio-
logical identifier, regardless of the identifier system that is used to annotate the pathway. For 
example, when the query is an Affymetrix probeset identifier, all pathways containing genes 
that map to that probeset will be returned.
The web service also allows client software to publish information to WikiPathways. New 
pathways can be uploaded and pathways can be modified or labeled according to quality 
standards. This enables scripts to perform quality monitoring and notification to assist the 
manual community-based curation process. This concept has already been successfully ap-
plied to other wiki’s, such as Wikipedia [7]. To prevent scripts from systematically overwriting 
pathways with invalid data, write access to the web service is restricted to a subset of user ac-
counts. Users who require write access for their script can request it from the WikiPathways 
site administrators.
34
To assist programmers in building applications that use the WikiPathways web service, sever-
al toolkits and programming libraries exist. Libraries to handle SOAP requests and responses 
are available for practically any programming language. Additionally, several bioinformatics 
tools, such as Taverna and GenePattern, support plugging in SOAP web services by writing 
only little or no extra code. This makes it easy to integrate WikiPathways in existing pipelines. 
To facilitate working with the GPML pathway format, we maintain an open-source Java li-
brary that provides a high-level API to process GPML. This library contains methods to read 
and write pathways in several file formats and to modify information in the pathway. Fur-
thermore, it provides an object-oriented interface to the WikiPathways web service, includ-
ing support for caching downloaded pathway information locally to improve performance. 
For each described use-case, example code is provided that demonstrates the use of available 
toolkits and libraries. The supplementary data include a list of useful libraries in several pro-
gramming languages.
Web applications
The web service can be used to build web applications that provide end-users access to spe-
cific WikiPathways functionality. Research groups can build a website that queries, processes 
and presents information from WikiPathways in a fully customized way. As an example, we 
implemented two web applications, each highlighting a unique functionality of the web ser-
vice. The first application is an improved search application with more advanced functional-
ity, available at http://search.wikipathways.org. The default WikiPathways search is based on 
a Google Custom Search Engine and allows searching through all the text on pathway pages, 
but doesn’t use the biological context that is defined in the GPML format. The improved 
search application uses the web service functions that query the Lucene index and allows us-
ers to perform searches with biological context, such as using biological identifiers and filter-
ing by species. Furthermore, the results are presented as thumbnail images, making it easier 
to choose the relevant result.
The second example is a web application that demonstrates integration of pathway informa-
tion with other types of data. This application visualizes gene expression information from 
ArrayExpress Atlas [8] on a WikiPathways pathway. ArrayExpress Atlas is a curated set of 
gene expression datasets that are publicly available. In this example, the user can specify a 
pathway from WikiPathways and a set of experimental conditions defined in ArrayExpress 
Atlas. First, all gene identifiers on the pathway will be mapped to Ensembl using the synonym 
database. The resulting Ensembl identifiers are passed to the ArrayExpress Atlas web service, 
which returns the corresponding experiments and p-values for the differentially expressed 
genes. Second, the WikiPathways web service will be used to download a colored version of 
the pathway image that will be displayed to the user (figure 2). This application can be used to 
get a quick overview of how known pathway interactions relate to observed gene expression 
in a given experimental condition and is available at http://atlas.wikipathways.org. Currently, 
716 of the 1000 experiments on ArrayExpress Atlas can be mapped onto at least one of the 
WikiPathways pathways, representing 9357 unique genes affected in one or more experiments 
across 7 different species.
Research groups are encouraged to build their own client-side web applications based on the 
WikiPathways web service and our open source libraries. This could include applications that 
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present WikiPathways content in a customized way or integrate pathways with other data. 
For example, research groups focused on metabolic pathways could create an application that 
presents the pathways in combination with detailed enzymatic information, while the genet-
ics community could create a web application that combines polymorphism information with 
the genes from a pathway.
 Assisting community-based curation
The biology community manually moderates the content on WikiPathways. Being able to 
quickly respond to mistakes as well as acts of vandalism is an important aspect of community-
based curation [9]. Many types of erroneous data can be identified automatically. For example, 
wrongly annotated gene, protein, or metabolite entities are identified by a simple computer 
script. The web service enables us to create “bots” that continually watch the pathway content 
for errors and notify curators when incorrect information is introduced. Currently, various 
types of bots run on a daily basis and check for incorrect database annotations, missing lit-
erature references, or incorrectly defined interactions. Each bot generates an HTML report 
that provides statistics and an overview of pathways that need to be corrected. By monitoring 
these reports over time, we can assess the effectiveness of community-based curation.
Community involvement in pathway curation on WikiPathways could be further stimulated 
by using the web service to build applets that can be included in any webpage or desktop. 
These applets could display user-specific information, such as recent changes on pathways 
Figure 2: Web application that integrates pathways with gene expression information. Pathway and gene expression information 
are retrieved from the WikiPathways and ArrayExpress Atlas web services respectively. A Java servlet integrates this informa-
tion and publishes it to an interactive web application. In this web application, users can view the information on an interactive 
pathway diagram.
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that have been edited by the user, recent discussion items, or listing other users that are in-
terested in similar pathways. Users could install this applet on their own webpage or on their 
desktop, for example using Google Gadget interface [10].
Querying interactions in Cytoscape
WikiPathways includes interactions between biological entities that can be represented as 
interaction networks. For example, metabolic reactions or protein activation events that are 
defined in a pathway can be viewed as binary interactions that form a graph. This enables 
network-based analysis [11] and integration with various datasets, such as protein-protein 
interactions [12,13]. Cytoscape [14] is a widely used tool for visualization and analysis of 
biological networks. The core Cytoscape functionality can be extended by external developers 
via a plug-in mechanism. We used this mechanism to build a plug-in that allows Cytoscape to 
work with GPML pathways [2]. We recently extended the plug-in with functionality from the 
WikiPathways web service. This new functionality makes it possible to search for pathways on 
WikiPathways directly from within Cytoscape, and these pathways can be loaded as an inter-
action network and then analyzed and integrated with experimental data [15]. Furthermore, 
existing networks in Cytoscape can be expanded with interactions defined in WikiPathways. 
Network analysis of biological pathways can also be a useful tool to augment pathways with 
knowledge from various resources. For example, cross-talk between biological pathways can 
be identified by projecting pathways on large protein-protein interaction networks [16]. The 
Cytoscape plug-in is a typical example of how the web service can be used to enrich external 
analysis tools with pathway content.
Future versions of WikiPathways will allow the user to define the semantic meaning for each 
interaction in a pathway. This can be used to improve the web service with functions that 
query and filter interactions based on this semantic information. For example, queries, such 
as “show me all proteins that inhibit phosphorylation of protein X” could be performed. In-
cluding semantics also opens new possibilities for analysis in Cytoscape, for example the sig-
naling pathway impact factor analysis method [17], which can use the distinction between 
activation or inhibition interactions.
Integration in bioinformatics workflows
A primary difficulty in bioinformatics is integrating erratically formatted data from different 
resources [17,18]. The development of web services for biological databases makes this easier 
and enables usage of workflow tools, such as Taverna [19]. Taverna provides a framework for 
creating workflows that integrate and process different types of data. For instance, a workflow 
could be used to integrate microarray experiment data with quantitative trait loci to filter for 
relevant genes [20]. Knowledge represented as a pathway is especially suited for integration 
with other biological data, since it typically covers multiple levels of the biological information 
hierarchy. Transcriptomics, proteomics, or metabolomics data can be integrated with pathway 
information to aid in the understanding of the underlying biological mechanisms. We cre-
ated several Taverna workflows based on the WikiPathways web service, such as a workflow 
that finds relevant pathways based on a list of over-expressed genes, proteins, or metabolites. 
These workflows can be downloaded from http://www.myexperiment.org/packs/30. Other 
possible workflows that could be implemented in Taverna include cross-species comparisons 
CHAPTER 4 37
of pathway information, or batch visualization of expression data.
The WikiPathways web service could be used as framework for building data analysis tools 
that make use of pathway information. Pathways can be used for visualizing experimental 
data in a biological context [21], finding relevant biological mechanisms and improving sta-
tistical power of an experimental analysis [22,23]. The WikiPathways web service provides 
all of the functionality necessary to perform these methods. Pathways can be downloaded as 
images where the pathway components can be given user defined colors, allowing for experi-
mental data analysis. Genes, proteins and metabolites are linked to several identifier systems, 
providing information to perform enrichment analyses.
Integration with online databases
Pathways typically consist of different types of biological entities, such as genes, proteins and 
metabolites. For each entity type, different biological databases are available, and each pres-
ents unique information about the entities in a different way. With the WikiPathways web 
service, we aim to encourage database developers to integrate pathway information into their 
online data presentation to provide more biological context. WikiPathways links pathway 
components to over 50 supported biological databases, including Entrez Gene, Ensembl, Af-
fymetrix, ZFIN, TAIR, and ChEBI. Tools that use information from any of these databases 
can use the web service to retrieve relevant pathway information per biological entity. For 
example, the list of pathways that contain a given gene identified by an Ensembl ID could 
be retrieved and displayed on the Ensembl web page for that gene or any website indexed by 
Ensembl identifiers. The website could display the pathway name, URL and/or thumbnail 
image of the pathway. A similar approach could be taken by metabolic databases (e.g., Pub-
Chem, ChEBI, or ChemSpider), protein databases (e.g., UniProt), model organism databases 
(e.g., MGI, ZFIN, WormBase, FlyBase, or TAIR), measurement platforms (e.g., Affymetrix, 
Illumina, or Agilent), or even literature databases, such as PubMed.
Future versions of WikiPathways will support the export of pathways in BioPAX format. This 
will make it easier to integrate WikiPathways with other pathway databases and resources, 
such as PathwayCommons. This functionality will be available in the web service, so that 
integrated pathway resources can easily keep the pathway information from WikiPathways 
up-to-date.
Conclusions
The WikiPathways web service provides an interface for programmatic access to community-
curated pathway information. It provides a flexible framework for building or extending tools 
that use pathway information from WikiPathways. The web service can be used by software 
developers to build or extend tools for analysis and integration of pathways, interaction net-
works and experimental data. The web services are also useful for assisting and monitoring 
the community-based curation process. By providing this web service, we hope to help re-
searchers and developers build tools for pathway-based research and data analysis.
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Abstract
Background: Complex phenotypes such as insulin resistance involve different biological 
pathways that may interact and influence each other. Interpretation of related experimental 
data would be facilitated by identifying relevant pathway interactions in the context of the 
dataset. Results: We developed an analysis approach to study interactions between pathways 
by integrating gene and protein interaction networks, biological pathway information and 
high-throughput data. This approach was applied to a transcriptomics dataset to investigate 
pathway interactions in insulin resistant mouse liver in response to a glucose challenge. We 
identified regulated pathway interactions at different time points following the glucose chal-
lenge and also studied the underlying protein interactions to find possible mechanisms and 
key proteins involved in pathway cross-talk. Conclusions: Studying pathway interactions pro-
vides a new perspective on the data that complements established pathway analysis methods 
such as enrichment analysis. This study provided new insights in how interactions between 
pathways may be affected by insulin resistance. In addition, the analysis approach described 
here can be generally applied to different types of high-throughput data and will therefore be 
useful for analysis of other complex datasets as well.
Introduction
Biological pathways provide a powerful medium to explore and reduce the complexity of 
large datasets. Pathways organize genes, proteins, metabolites and their interactions into 
functional groups, often visualized as diagrams or networks. A commonly employed analysis 
technique using pathways is enrichment analysis, where pathways are represented as gene 
sets and where the aim is to find those sets that are enriched with entities of interest, such 
as differentially expressed genes [1]. This allows a researcher to get an overview of biological 
processes that are likely to play a role in the studied phenomenon. The result of enrichment 
analysis is a sorted list of pathways, which is easier to interpret than a list of thousands of 
individual significantly expressed genes. However, each pathway in this list is presented as an 
isolated entity, while in reality these pathways can interact, for example through interacting or 
shared proteins and metabolites. To aid further exploration and interpretation of gene set en-
richment results, it would be useful to get insight in possible relations or interactions between 
pathways and how these are affected in the context of the studied phenotype.
One way to get insight in possible relationships between pathways is to look at their overlap 
in gene, protein or metabolite content. Pathways with a high overlap might be related by 
shared paths. Tools such as ClueGO [2] and EnrichmentMap [3] allow the user to convert 
the list of enriched pathways into a network by calculating overlap between the sets. We used 
another approach with bi-partite graphs to create a network based on overlap in significantly 
regulated genes [4].
Another more functionally based approach is to find possible pathway cross-talk by looking 
at protein interactions between pathways. Cross-talk allows multiple pathways to exchange 
signals and influence each other. For example, the P53 pathway can control the Cell Cycle 
pathway by regulating the expression of p21 and can itself be activated by several pathways, 
for example the MAPK pathway. Metabolic pathways may share enzymatic reactions and may 
influence each other by influencing the availability of a substrate. These forms of pathway 
cross-talk are highly context dependent, for example, interactions between the P53 pathway 
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and Cell Cycle depend on several external stress factors such as DNA damage or oxidative 
stress. Previous studied have already used protein interaction networks to study pathway in-
teractions in a given context. Kelley and Ideker [5] integrated protein interactions with data 
from genetic interaction analyses in yeast and found that the largest part of genetic interac-
tions could be explained by interactions between pathways. In two other studies [6,7] a path-
way cross-talk network was built based on direct interactions between the proteins in human 
pathways. Both studies were based on the assumption that a pair of pathways is likely to 
interact when a higher number of protein-protein interactions are found between them than 
would be expected by chance. The work of Li et al. resulted in a scale-free pathway cross-talk 
network in which pathways in the same broad functional category indeed cluster together. 
Transcriptomics data was integrated into this network by finding cliques (a subset of path-
ways in which every two pathways are connected) which contained highly enriched pathways. 
Huang et al. performed a similar study, but also considered overlapping proteins between the 
pathways and integrated transcriptomics data at the protein level by counting only interac-
tions between proteins encoded by differentially expressed genes. This resulted in context 
specific networks, reflecting interactions between pathways within the context of the dataset.
In this study, we investigate interactions between pathways by finding regulated paths be-
tween pathways for a given transcriptomics dataset. While the methods of Li et al. and Huang 
et al. only consider direct protein interactions between pathways, considering paths spanning 
multiple interactions may detect indirect interactions as well. Indirect interactions consist of 
paths including one or more proteins that are not annotated to a pathway, but do have known 
interaction or binding partners. In case the majority of the genes encoding these proteins and 
their interacting partners in two different pathways would be differentially expressed in a giv-
en condition, this indicates a potentially relevant path through which these pathways interact. 
An algorithm to detect pairs of pathways that contain such a path would allow researchers to 
directly explore and visualize possible paths along which pathways might interact in a given 
context. Furthermore, the inclusion of proteins that have not yet been annotated to a pathway 
in the analysis makes it possible to look beyond well studied processes, increasing the chance 
of generating novel hypotheses.
We designed a method to detect both direct and indirect interactions between pathways and 
visualize the resulting paths and applied this method to a transcriptomics dataset from the 
European Nutrigenomics Organization (NuGO) PPS2 study [8] to investigate the response to 
a glucose challenge in liver samples from obese and insulin resistant, as well as normal mice. 
Insulin resistance is a complex disease, not limiting to metabolism, but also associated to for 
example inflammation [9]. Interactions between different pathways might be especially rel-
evant in the context of such complex phenotypes. Using this dataset, we hope to gain insight 
in the regulated biological processes during the response to the metabolic stressor glucose 
and the influence of a pretreatment with a high-fat diet on this response.
Results
To find potentially regulated paths between different pathways, we designed a generic method 
based on non-redundant shortest paths in a weighted graph. The required input data are:
•	 A set of pathways, each pathway consisting of a collection of gene, protein and/or me-
tabolite entities.
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•	 An interaction network, providing interactions or functional associations between genes, 
proteins and/or metabolites, which can be compiled from different resources.
•	 A weight value for each edge in the interaction network, indicating how much an edge 
will contribute to the length of a path. This can be based on experimental data, for ex-
ample the expression of the genes that the edge connects.
For each pathway pair, a score is calculated by finding the set of non-redundant weighted 
shortest paths that have a length which is smaller than a given threshold and do not cross 
any other pathway. The length of a path is defined by the sum of the edge weights in the path. 
The score for a pathway pair depends on the number of paths found and their length (Figure 
1C). The more and shorter the paths found between two pathways, the higher the score. To 
indicate the significance of an interaction between two pathways, a p-value is calculated by 
comparing the score to an empirical null distribution based on re-sampling of the pathways 
(see methods). A pathway network is generated by creating an edge between a pathway pair if 
their p-value is smaller than a given significance threshold.
This method was applied to pathways from the WikiPathways [10] and KEGG databases [11], 
which after merging strongly overlapping pathways resulted in a set of 236 pathways covering 
6953 genes. A directed interaction network was generated based on reactions in these path-
ways and extended with reactions, functional associations between proteins, protein-protein 
interactions and transcription factor targets from several public databases (see methods). The 
resulting interaction network consisted of 6893 proteins and 138,105 interactions. Because 
a subset of interactions in this network have a specified direction (e.g. transcription factor 
Figure 1: Overview of the analysis approach to investigate interactions between pathways. A: Information from different resourc-
es and experimental data is integrated into a weighted gene/protein interaction network and a set of pathways and their associated 
genes and proteins. B: Based on the interaction network, an interaction score and significance is calculated for each pathway pair. 
C: Example of the process of identifying a set of non-redundant shortest paths for the interaction of pathway P1 to P2. This panel 
shows step 5-7 of the calculation as described in the Methods section. D: Two representations of the resulting pathway interac-
tions. The top panel shows the pathway interaction network, where each edge represents a significant interaction between two 
pathways. The bottom panel shows a detailed network showing the identified shortest paths between pathways P1, P4 and P2.
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targets), the identified interactions between pathways are directed as well.
Pathway interactions were investigated in the context of a transcriptomics dataset of mouse 
liver samples. This dataset contains gene expression measurements before (t=0) and at 0.6 
hour (t=0.6), 2 hours (t=2) and 48 hours (t=48) after a glucose challenge in two groups of 
mice fed either a low fat (LF) or high fat (HF) diet for 12 weeks before the challenge. Af-
ter these 12 weeks all mice fed with HF diet had become obese and had developed insulin 
resistance [12]. To test for differential gene expression between different groups, in total 7 
comparisons were made. Firstly, to determine the baseline effect of the different diets on gene 
expression, the measured genes were tested for differential expression between the HF and LF 
samples at t=0. Secondly, to determine the changes in gene expression following the glucose 
challenge in each individual diet group, the genes were tested for differential expression be-
tween t=0 and each other time point (t=0.6, t=2 and t=48 hours). Each comparison resulted 
in a T-statistic for every gene representing the significance and direction of differential ex-
pression. The number of differentially expressed genes (q < 0.01) is shown in Table 1. For 
the number of differentially expressed genes in the glucose challenge response, the two diet 
groups display a different trend. In the LF group, the number of significant genes grows over 
time and is highest at t=48, indicating that even 48 hours after the challenge gene regulation 
has not returned to the initial situation. However, in the HF group, the number of significant 
genes peaks at t=2 and decreases again at t=48. For each of the comparisons, pathways were 
identified that were enriched with differentially expressed genes (Supplementary figure 1 and 
Table 1). The trend observed with respect to the number of differentially regulated genes in 
response to the glucose challenge is not apparent in the number of enriched pathways. Both 
the LF and HF groups show an increasing trend, where the number of enriched pathways at 
t=48 is higher than preceding time points in both groups.
Edge weights were derived from the T statistics of the comparisons to generate a weighted 
interaction network for each test. For each edge, the weight value inversely depends on the 
value of the T statistic of the target gene (see methods for details), receiving a low weight 
value if the gene is differentially expressed. Thereby, paths that include genes (or the proteins 
they encode for) that are differentially expressed will have a shorter length. The number of 
edges in each interaction network that have a weight smaller than the maximum path length 
and hence may contribute to a path between two pathways is shown in Table 1. These edges 
cover between 3.5% and almost 19% of the complete interaction network. The algorithm to 
Test Significant genes, q < 0.01 Enriched pathways, p < 0.05 Edges with weight <= lmax
HF vs LF, t=0 1971 (17.3%) 54 (22.9%) 24055 (16.8%)
LF t=0 vs t=0.6 24 (0.2%) 17 (7.2%) 5054 (3.5%)
LF t=0 vs t=2 573 (5.0%) 43 (18.2%) 13251 (9.2%)
LF t=0 vs t=48 1607 (14.1%) 57 (24.15%) 20220 (14.1%)
HF t=0 vs t=0.6 773 (6.7%) 13 (5.5%) 15784 (11.0%)
HF t=0 vs t=2 2815 (24.7%) 17 (7.2%) 26845 (18.7%)
HF t=0 vs t=48 736 (6.4%) 40 (17.0%) 16857 (11.7%)
Table 1: Gene and pathway statistics for each comparison: Number of significant genes, enriched pathways and edges in the 
interaction network that have a weight shorter than the maximal path length and hence contribute to the pathway interactions. 
Percentages are relative to the total number of measured genes, the total number of pathways and the total number of edges in the 
interaction network respectively.
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detect pathway interactions was run for each comparison, resulting in 7 pathway interaction 
networks. A Cytoscape [13] session file that contains an interactive visualization for each 
network is available as supplementary data.
The results of the algorithm can be represented as two different types of networks (Figure 
1D). First are the pathway interaction networks that provide a global overview of how path-
ways might relate without showing the underlying protein interactions. Hence, each node in 
this pathway interaction network represents a pathway and each edge is a significant interac-
tion between them. Second are detailed networks that also show the protein interactions that 
compose the paths between the pathways. These networks consist of two types of nodes, rep-
resenting either a pathway or a protein. An edge between a pathway node and protein node 
represents association of the protein to the pathway and an edge between two protein nodes 
represents an interaction between these proteins. The next paragraph provides an analysis 
of the generated pathway interaction networks by identifying pathways with a more central 
role in the network. This is followed by a global analysis of the protein interactions that form 
these pathway interactions, to identify proteins that may play an important role in pathway-
crosstalk in this dataset. Finally, several potentially interesting pathway interactions will be 
highlighted and investigated more closely by zooming in to their protein interactions via the 
detailed network representation.
Global analysis of the pathway interaction networks
The number of identified pathway interactions ranges from 25 to 207 across the different 
networks (Table 2). The differential expression between the HF and LF groups at t=0 (before 
glucose challenge, but after 12 weeks of diet intervention) results in the most interactions, 
while the early response to the glucose challenge in the LF group results in the fewest interac-
tions. For 66.7% of the pathways enriched with differentially expressed genes between the diet 
groups at t=0, at least one significant interaction with another pathway could be found. This 
number is much lower for the early response to the glucose challenge in the LF group (20% 
and 27.9%) and HF group at t=0.6 (23.1%).
To identify potential focal pathways in the network, we can look at several node centrality 
measures. Supplementary figure 2 shows the degree (number of interactions with other path-
ways) of the most connected pathways. Since the pathway interactions are directional, we can 
make the distinction between in-degree and out-degree. A pathway with a high in-degree 
Test Nodes (pathways >= 1 interaction) Enriched nodes Edges (p < 0.001)
HF vs LF, t=0 123 (52.1%) 36 (66.7%) 207
LF t=0 vs t=0.6 17 (7.2%) 5 (20.0%) 25
LF t=0 vs t=2 57 (24.2%) 12 (27.9%) 52
LF t=0 vs t=48 82 (34.8%) 27 (47.4%) 108
HF t=0 vs t=0.6 43 (18.2%) 3 (23.1%) 54
HF t=0 vs t=2 111 (47.0%) 10 (58.8%) 160
HF t=0 vs t=48 82 (34.8%) 19 (47.5%) 92
Table 2: Statistics for each pathway interaction network: Number of pathways and enriched pathways in the network that have at 
least one significant interaction and the number of significant pathway interactions. Percentages are relative to the total number of 
pathways and total number of enriched pathways respectively.
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is the target of many pathway interactions, which may indicate that the pathway is strongly 
regulated. A pathway with a high out-degree is the source of many pathway interactions, 
which may indicate a role in regulation of different targets. The three pathways with the high-
est in-degree for the network resulting from the comparison between diets at t=0 are three 
stress response and apoptosis related pathways: Oxidative damage and apoptosis (14 interac-
tions), FAS pathway and stress induction of HSP70 (14 interactions) and Apoptosis and its 
regulation by HSP70 (10 interactions). The first two pathways share 11 neighbors among their 
incoming interactions and 7 neighbors are shared among all three pathways. Interestingly, 5 
of these 7 shared neighbors are in the top pathways with highest out-degree and 4 of those 
are also enriched with differentially expressed genes (p < 0.05). For most of the pathways with 
the highest in-degree, the out-degree is zero or very low and the corresponding node is act-
ing like a sink, or end point. The same holds the other way around, where pathways with the 
highest out-degree tend to act as a source. To find pathways that may have a gatekeeper role 
in the network, we can look at the betweenness centrality, which measures how often a path-
way occurs on shortest paths between the other pathway nodes in the network. The higher 
the betweenness, the more the pathway can control interactions between other pathways in 
the network. Supplementary figure 3 shows the betweenness centrality of the pathways with 
highest betweenness. Notable are the many cytokine related pathways that all have a high be-
tweenness in the network for the response at t=2 in the HF diet group. None of these central-
ity measures seem to correlate with enrichment of the pathway and a pathway does not have 
to be enriched with differentially expressed genes to exhibit a central position in the pathway 
interaction network.
Protein interactions contributing to regulated paths between pathways
Studying the protein interactions and functional associations that form differentially regu-
lated paths between pathways may provide insights in the mechanisms of interacting path-
ways and reveal potential key regulators of pathway cross-talk that play a role in the dataset. 
The number of paths contributing to each pathway interaction network ranges from 52 for 
the smallest network (LF response at t=0.6) to over 1500 for the largest (comparison between 
diets at t=0). Most paths consist of direct interactions between proteins in the interacting 
pathways (Supplementary figure 4). Only 17% of the paths over all networks are indirect and 
have one intermediate protein, while only 1 path has two intermediate proteins. The network 
for the response in the LF group at t=48 consists of almost 50% of indirect paths, a consider-
ably larger part than the other networks.
Test Unique protein interactions Number of unique proteins Unique proteins not in a pathway
HF vs LF, t=0 440 198 25
LF t=0 vs t=0.6 8 6 0
LF t=0 vs t=2 47 43 1
LF t=0 vs t=48 275 142 14
HF t=0 vs t=0.6 53 47 0
HF t=0 vs t=2 400 200 18
HF t=0 vs t=48 118 86 2
Table 3: Number of unique proteins and protein interactions that contribute to the paths between pathways for each network.
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There is a lot of overlap among the paths between pathways, since the number of unique pro-
tein interactions that form these paths is much lower than the number of paths itself (Table 
3). For example, for the comparison between the diet groups at t=0, the 1562 paths between 
pathways are formed by only 440 unique protein interactions. The high overlap of protein in-
teractions in the paths between pathways indicates the presence of proteins that are involved 
in multiple paths and might act as key regulators of pathway interactions. Supplementary 
Table 1 shows the proteins that are involved in most pathway interactions per network. Most 
of these proteins participate in interactions with highly connected pathways and a large part 
is involved in well-known signaling processes such as Kras and Mapk1, transcription factors 
such as Jun and cytokines such as Il1a and Il1b. There is some overlap of these proteins be-
tween the different networks, but there are no proteins that are in the top ten for each time 
point. One protein that plays a significant role in multiple networks is Pik3r1, which is known 
to play a role in insulin signaling by activation through IRS-1 [14] and participates in most of 
the paths for the networks for the response in the HF group at t = 2 and t = 48.
Figure 2: An indirect interaction between the Axon Guidance and Insulin Signaling pathways in the network for the comparison 
between HF and LF diet at t=0. Left: Network representation of the identified path between the two pathways, consisting of three 
proteins Gsk3b, Sgk3 and Tsc1. Right: The location of these proteins in the KEGG pathway diagrams. The newly found indirect 
interactions have been added in red.
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Proteins that act as intermediate in indirect interactions between pathways are of special in-
terest. They are not annotated to any pathway yet, while they do seem to play a role in the con-
text of this dataset, so studying their interactions may lead to new findings that would have 
been missed by looking at the annotations in the pathways alone. Table 3 lists the number of 
such proteins per network. Interestingly, while the network for LF at t=48 contains relatively 
many indirect interactions, the number of proteins playing a role in indirect interactions is 
lower than expected. Upon closer inspection, the high number of indirect paths is mainly due 
to binding interactions of a single set of proteins (including differentially expressed Mapre3, 
Cep57, Tubg1 and Nedd1) that are not annotated to a pathway, but do all bind to a few proteins 
that play a role in many different pathway interactions, such as Ywhab, Prkaca, Tubb5 and 
Hsp90ab1. One of the proteins that is not annotated to any pathway is Sgk3 which plays a role 
in several pathway interactions for the response to the glucose challenge in the LF diet group 
at t=2 and t=48 (Supplementary figure 5) as well as the comparison between the diet groups 
at t=0 (Figure 2). In the latter, Sgk3 interacts with Gsk3b and Tsc1 to form one of the paths that 
form the identified interaction between the Axon guidance and Insulin signaling pathways. 
The genes encoding for these three proteins are all down-regulated in the HF diet group (q 
< 0.01). Since Gsk3b is present in both the Axon guidance and Insulin signaling pathways, in 
addition to the possible interaction between the two pathways via Sgk3, it might also form an 
alternative route within the Insulin signaling pathway that has been differentially regulated in 
the HF diet group (Figure 2).
Visual exploration of the pathway interaction networks
The pathway interaction networks might be powerful tools for interactive exploratory analy-
sis, by browsing and filtering the network visualizations in different ways to find interesting 
structures. The structural properties discussed above may guide to the most relevant parts of 
each network, which can then be explored in more detail. In this section we highlight several 
notable pathway interactions for each network and investigate the protein interactions that 
form the paths between the pathways. 
Differential expression between the LF and HF group
The network for the comparison between the diet groups at t=0 may provide insight in the 
changes contributing to and resulting from the development of insulin resistance after feed-
ing of a HF diet. Due to the large size of this network, and to aid visual exploration, we only 
include pathway interactions for which at least one of the participating pathways is signifi-
cantly enriched (p < 0.05) with differentially expressed genes. Based on this filtered network, 
we study several potentially interesting interactions and subgraphs. A good starting point for 
this exploration might be the 3 apoptosis and stress response related pathways that have the 
highest in-degree in the network. Interestingly, 8 out of 14 pathways interacting with at least 
one of the three apoptosis related pathways also have an incoming interaction from the ESC 
pluripotency pathway, which is significantly enriched (p < 0.01). This pathway has a strong in-
teraction (consisting of 38 paths) with the Proteasome pathway, which is also significantly en-
riched (p < 0.01). The remaining pathways interacting with the 3 apoptosis related pathways 
include 4 pathways with a relatively high out-degree of which 3 are significantly enriched (p 
< 0.05), and two versions of the Wnt signaling pathway, which both have a strong connection 
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(25 and 27 paths) with the significantly enriched TNF-alpha NF-kB Signaling Pathway (p < 
0.05). The subgraph containing these pathways and their interactions is shown in Figure 3A.
Based on this subgraph, we can “zoom in” to view the individual protein interactions that 
comprise the paths between the interacting pathways. For example, the paths between the 
3 apoptosis related pathways and their neighbors are shown in Figure 3B. Despite the many 
neighbors of these three pathways, the number of unique proteins in these neighbors con-
tributing to the interaction is relatively low (15 proteins for 14 pathways) and hence many 
Figure 3: Pathway interactions and detailed network visualization for the interactions with the three apoptosis related pathways 
for the comparison between HF and LF diet at t = 0. A: Subgraph of the pathway interaction network, based on incoming interac-
tions to three stress response and apoptosis pathways with the highest in-degree. Pathway nodes with a thick border are signifi-
cantly enriched (p < 0.05). B: The protein interactions that compose the interactions between the three apoptosis related pathways 
and their neighbors in the subgraph as shown in box A (see inset, included interactions are colored orange). Protein nodes have a 
thick border when they are significantly differentially expressed (q < 0.05).
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of these proteins are annotated to more than one of the source pathways. This indicates the 
presence of common paths, shared by different pathway interactions. Indeed, there seem to 
be two main paths shared across different pathway interactions. Firstly, Raf1, Kras, Nras and 
Prkcb are present in more than 10 of the source pathways and all form a path to the three 
target pathways via Map3k1, which participates in 53 paths between the pathways. Secondly, 
there is a distinct path through Prkar1a, which forms an interface to the Gap junction, Long 
term depression and Wnt signaling pathway via indirect binding interactions with Ppp2r1a, 
Tuba4a and Tubb5. Ppp2r1a may also play a role in the interaction with the TNF-alpha NF-
kB Signaling pathway and two versions of the Wnt pathway via indirect binding interactions 
with Ywhab (Supplementary figure 6C). Since this is an indirect interaction, involving pro-
teins that have not been annotated to one of the pathways, this is a target for further study 
to elucidate the potential role of these proteins in interaction between these two pathways. 
The link between the Proteasome and ESC pluripotency pathway can be largely explained 
by interactions between differentially expressed subunits of the proteasome and Gsk3b, Apc 
and Ctnnb1 (beta-catenin). The pathway diagram of the ESC pluripotency pathway reveals 
that these interactions are part of Wnt signaling and can influence the concentration of beta-
catenin by targeting it for proteolysis after phosphorylation by Gsk3b and Apc. Interestingly, 
Ctnnb1 and Gsk3b are also present in other interactions, connecting the TNF-alpha NF-kB 
signaling pathway to the Wnt signaling pathways, the B-cell and T-cell receptor pathways to 
the Oxidative damage and apoptosis pathways via Akt2, Casp7 and Trp53, and the ESC plu-
ripotency pathway to the B-cell and T-cell signaling and Chemokine signaling pathways via 
Crk, Nfatc2 and Chuk.
In addition to the pathways with a high degree, the network contains a potentially interest-
ing component consisting of 10 metabolic pathways for which interactions with the Primary 
bile acid biosynthesis and Peroxisome pathways have been found. Out of the 12 pathways in 
this component, 9 are significantly enriched (p < 0.05). When looking at the protein interac-
tions that form the interactions between these pathways, it turns out to be comprised of two 
binding interactions between Hadh, Hsd17b10 and Hsd17b4 (Supplementary figure 7). These 
binding interactions are assigned by the STRING database [15] as subunits of a single enzyme 
complex, but in reality they are three distinct isozymes of 3-hydroxyacyl-CoA dehydrogenase 
[16,17]. Therefore, these proteins are probably not binding, but rather catalyzing a similar 
reaction in each of these pathways. While these proteins are differentially expressed and may 
play a role in insulin resistance and response to HF diet, they are not likely to contribute to an 
interaction between these pathways. 
Early response to the glucose challenge
The networks based on differential expression between t=0 and each other time point after 
the glucose challenge in the LF group provide insight in pathway interactions that play a role 
during the response to the glucose bolus in mouse liver. The low differential expression at 
t=0.6 in the LF group (only 24 significant genes, q < 0.05) is reflected in the small size of the 
corresponding network. Studying the protein interactions for that network reveals that all 
identified pathway interactions include Jun and Fos, for which the gene expression has both 
increased more than 5-fold compared to t=0, and Il1b with a 2.5 fold increase (Supplemen-
tary Figure 8). Part of the interactions also includes Il1a, which is differentially expressed 
with a more than 2-fold increase. As a dimer, Jun and Fos form the AP-1 transcription factor, 
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which responds to several stimuli including cytokines and controls several processes such as 
apoptosis and proliferation, for all of which related pathway interactions are identified. The 
network for the HF group at t=0.6 shows a high overlap with the corresponding network for 
LF, including almost all edges of the LF network. The protein interactions and expression for 
these overlapping edges are similar to those in LF (Supplementary Figure 8), indicating that 
these interactions via AP-1 remain unaffected by obesity and insulin resistance. In addition to 
the largest component of the network for HF at t=0.6, which is largely spanned by the interac-
tions with Jun and Fos, there are several small components of isolated interactions between 
two or three pathways, which are not present in the LF network. For example, one of the com-
ponents is composed of the Antigen processing and presentation and Spliceosome pathways, 
both interacting with the Lysosome pathway. These interactions have been identified because 
two genes encoding for proteins of the HSP70 family, Hspa1a and Hspa1b, are differentially 
expressed (>4 fold) and interact with Ap1s1, Ap1b1 and Cltc. These proteins are involved in 
transport of lysosomal enzymes and show moderate, but not significantly differential expres-
sion (Supplementary figure 9). Another potentially interesting component that consists of 
three pathways provides an interaction between the S1P receptor pathway, the Ribosomal 
proteins pathway and Insulin signaling pathway via Mapk7, Nr4a1 and Sgk1, which are all 
significantly up-regulated compared to t=0 (Supplementary figure 10), and Rps6kb2, which 
is up-regulated albeit not significantly (q = 0.066). Based on the pathway diagram, Mapk7 
is a downstream target of the S1P receptor pathway, but because the other proteins in this 
pathway do not show significantly differential expression, it does not seem likely that the dif-
ferential expression of Mapk7 is related to upstream activities in this pathway. However, since 
Mapk7 is present in the insulin signaling pathway as well, this might point to an alternative 
path within the insulin signaling cascade, which may be affected by HF diet in response to 
the glucose challenge. The networks for t=2 show much more difference between the HF and 
LF diet. There are only two overlapping pathway interactions and in addition, the network for 
LF is much less connected. A large part of the connectivity in the HF network situates around 
the merged version of the Cytokine-cytokine receptor interaction pathway and Cytokines and 
inflammation pathways (Cytokine pathway), which has the highest betweenness centrality. 
Several receptors listed in this pathway are differentially expressed, such as Il1r1 and Il1r2, 
involved in a path to Apoptosis and oxidative stress via Casp8 and Casp9. All other receptors 
that contribute to the pathway interactions, including up-regulated Igf1r, Erbb3, Egfr and 
down-regulated Kdr and Fgfr4, are receptor tyrosine kinases and form a path to several spe-
cific interleukin signaling pathways, T-cell and Kit receptor pathways via the Cbl protein. Cbl 
is a ubiquitin-protein ligase that can target these receptors for endocytosis [18]. Its expression 
profile shows a peak at t=2 in the HF group only, where the expression has increased almost 
2-fold compared to t=0. We also found that the Endocytosis pathway, which indeed contains 
Cbl and the receptor tyrosine kinases as well, shares all its interacting pathways with the Cy-
tokine pathway. In addition to Cbl, the interactions between the Endocytosis pathway and its 
neighbors also include the up-regulated Cltc and Cltb, which encode for the two light chains 
of clathrin, as well as several other proteins that are involved in clathrin dependent endocy-
tosis (Supplementary figure 11). This endocytosis mechanism is known to be responsible for 
transporting receptor tyrosine kinases to the endosome after ubiquination by Cbl [18]. To-
gether, these interactions indicate that removal of these receptors from the cell membrane is 
affected at this point in the glucose challenge in the HF diet group specifically.
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Late response to the glucose challenge
A notable aspect of the late response to glucose challenge is that the LF group contains many 
more differentially expressed genes than at the early time points, while in the HF group the 
number peaks at t=2 and is lowest at t=48. This difference is not reflected in the pathway 
interaction networks for t=48, which both contain almost the same number of nodes and 
edges. However, the overlap between these networks is small; only 4 edges are present in 
both networks, including the interaction between the TGF-beta receptor signaling Pathway 
and Proteasome. Interestingly, the proteins in the paths between these two pathways with 
the TGF-beta and Proteasome pathways behave differently between the HF and LF group 
(Supplementary figure 12). All genes encoding the participating proteins in the Proteasome 
pathway are down-regulated in the LF network and up-regulated in the HF network. The 
proteins Cdc27 and Ctnnb1 in the TGF-beta pathway show a similar pattern. The interaction 
in the LF network contains another protein, Axin1, which is significantly up-regulated in the 
LF group and slightly down-regulated in the HF group is not included in the latter interaction 
due to its low significance.
The network for the LF group contains one tightly connected cluster, held together by the 
Antigen processing and presentation and T Cell receptor signaling pathways, including in-
teractions with the enriched Cell cycle and TNF-alpha NF-kB signaling pathways. There are 
several central proteins in these interactions, including a set of shared binding partners be-
tween Ywhab in the Cell cycle and TNF-alpha pathways and Tubb5 in the T Cell Receptor 
pathway, or Hsp90ab1 in the Antigen processing pathway (Supplementary figure 13). The 
Gab1 protein in the TNF-alpha pathway directly interacts with several proteins in the T Cell 
pathway, including the down-regulated Fyn and Sos2, and up-regulated Pik3r2 and Pxn. In 
addition, Prkaca is present in most neighbors of the Antigen processing and presentation and 
T Cell receptor signaling pathways, making it the protein involved in most paths for this net-
work. Another interesting structure in the network is the second order neighborhood of the 
Insulin signaling pathway, containing the Wnt and Il-6 signaling pathways and the Starch and 
sucrose metabolism pathway, which are all significantly enriched (Supplementary figure 14). 
A large part of the involved proteins are present in multiple of these pathways. For example, 
half of the proteins of the IL-6 pathway are also present in the Insulin signaling pathway. One 
of the proteins present in both the Wnt and IL-6 pathways, Gsk3b, forms an indirect path to 
the Insulin signaling pathway via Sgk3 which interacts with Trib3 and Tsc1, as well as a di-
rect interaction via Tsc1. Two enzymes Pygl and Gys2 participate in the interactions with the 
Starch and sucrose metabolism pathway, interacting with several proteins in the Insulin, IL-6 
and Wnt signaling pathways, which might indicate activated mechanisms that regulate these 
enzymes. The up-regulated Pygl gene encodes for glycogen phosphorylase which catalyzes the 
rate-limiting step in glycogen degradation. The down-regulated Gys2 gene encodes for glyco-
gen synthase, involved in conversion from glucose to glycogen. Together, this indicates that at 
t=48 the liver switches from storage of excess glucose to usage of the stored glycogen, possibly 
influenced by the pathway interactions identified here. The pathway interaction network for 
the HF response is typed by several key proteins including Pik3r1, Kras, and Ctnnb1. Kras 
and Ctnnb1 both have a protein interaction with Pik3r1 which plays a key role in many of the 
identified pathway interactions in this network. In addition, the up-regulated protein Mapk14 
also interacts with Kras and 8 out of 12 pathways that contain Mapk14 also contain Pik3r1. 
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Discussion
The goal of this study is two-fold. Firstly, we aimed to design methods for exploring possible 
pathway interactions in a specific context, which can be defined by an experimental dataset. 
Secondly, we explored pathway interactions relevant to glucose response in mouse liver and 
how these interactions are affected by high fat feeding-induced insulin resistance. We will 
first highlight several of the identified interactions and follow with a discussion about the 
described approach in general.
The high number of interactions with three apoptosis related pathways in the network for the 
comparison between diets at t=0 suggest involvement of apoptosis in insulin resistant liver. 
Even though these pathways are not enriched with differentially expressed genes, they are 
the end point of many pathway interactions from upstream signaling pathways, which sug-
gests that apoptosis is differentially regulated in the insulin resistant mice. Indeed, a relation 
between apoptosis and insulin resistance has been described before [19] and a recent study 
has shown that apoptosis might be increased in insulin resistant liver in humans [20]. The 
proteins identified could help to find mechanistic explanation for this observation, but it is 
hard to identify the most crucial step based on transcriptomics data alone, since many of the 
signaling events take place via post-transcriptional modifications.
The response to the glucose challenge at t=0.6 in both LF and HF is typed by the up-regula-
tion of Jun and Fos, together forming the transcription factor AP-1, and Il1a and Il1b. This 
might indicate that AP-1 initiates several processes in the early response to glucose, possibly 
activated by Il1, and that this mechanism is not influenced by obesity or insulin resistance. 
A previous study has demonstrated that Il1 might indeed activate AP-1 in a hepatocyte cell 
line [21]. Immediate early genes such as Jun and Fos are genes that are activated transiently 
and rapidly in response to a wide variety of cellular stimuli, including glucose [22]. They 
represent a standing response mechanism that is activated at the transcription level in the 
first round of response to stimuli, before any new proteins are synthesized. Our interaction 
network contains 7 target genes of AP-1, of which 4 are present in the dataset, but none are 
differentially expressed during the early response. A possible cause might be that AP-1 is not 
activated and therefore its expression has no consequences, however we cannot determine 
this with the current dataset. Because of the general role of AP-1, there are probably more 
targets than annotated in our interaction network, so it may be of interest to analyze this effect 
in more detail using more specialized bioinformatics approaches or identify possible targets 
in a follow-up experiment. In addition to this shared mechanism, we also identified several 
interactions unique for the HF group. Firstly, the expression of two proteins of the HSP70 
family show a distinct peak of over 4-fold increased expression at t=0.6 in the HF group, but 
not in the LF group. We identified a possible interaction of these proteins with the Lysosome 
pathway that may indeed play a role in this pathway by uncoating of clathrin-coated vesicles 
[23]. However, based on our data it is hard to judge the relevance of this finding, since the 
three proteins in the Lysosome pathway that may interact with the HSP70 proteins show only 
moderate, not significantly differential expression at t=0.6, their expression profiles do not 
correlate, and only a few additional genes in the Lysosome pathway itself show significantly 
differential expression at t=0.6. It may be more likely that another function of these HSP70 
proteins, for example their role as chaperones, could be related to their expression profile 
specific to the HF group. In addition, one of the two HSP70 proteins, Hspa1a (also known as 
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HSP72), was found to play a role in preventing insulin resistance and blocking inflammation 
in human muscle by preventing c-jun amino terminal kinase (JNK) phosphorylation [24]. 
Since JNK can activate the c-Jun transcription factor, which was also found to be differentially 
expressed at t=0.6, there may be a relation with the HSP70 proteins. Unfortunately neither 
the pathway collection nor the interaction network we used here contains any relevant inter-
actions which are altered at the transcriptional level and could provide more insight in this 
possible relation. Secondly, we identified an interaction between Mapk7, Rps6kb and Sgk1 in 
the Insulin signaling pathway and the transcription factor Nr4a1 in the Nuclear receptors 
pathway. Both Nr4a1 and Sgk1 show an expression profile with a peak at t=0.6 in both the 
HF and LF group, however Mapk7 and Rps6kb2 are only up-regulated in the HF group. This 
difference might indicate the presence of an alternative mechanism through which Nr4a1 can 
be activated. Nr4a1 is a known transcriptional regulator of genes involved in glucose metabo-
lism in mouse liver [25]. Because of the absence of any targets for this transcription factor in 
our interaction network we could not determine whether any downstream interactions to the 
Insulin signaling pathway are affected. Both the mRNA processing and Spliceosome pathways 
are significantly enriched for the differentially expressed genes at t=0.6 and together with the 
presence of several differentially expressed transcription factors and the HSP70 chaperones 
this indicates that the response to the glucose challenge at t=0.6 is mainly typed by a stress 
response and possibly transcriptional activation of genes to initiate the further response.
The most notable property of the pathway interaction networks for the glucose response at 
t=2 is the high centrality of the Cytokine pathway. This pathway summarizes different cyto-
kines and their receptors, and since several of these receptors are differentially expressed it 
makes sense that this pathway fulfills a central role in the network, by connecting to the dif-
ferent processes these receptors play a role in. We identified a regulated interaction between 
several cytokine receptor pathways and the Endocytosis pathway, which might point to in-
creased removal of receptor tyrosine kinases from the cell membrane in the HF group after 
ubiquination with the up-regulated Cbl protein. Several of the proteins participating in the 
interactions with the cytokine receptor and Endocytosis pathways are known to be related to 
insulin or even annotated to the Insulin signaling pathway. For example, Cbl plays an impor-
tant role in the CAP/Cbl/TC10 dependent transport of GLUT4 vesicles [26]. This could point 
to an interaction with the Insulin signaling pathway, but we did not identify a significant in-
teraction in our network. Upon closer inspection, however, an interaction with the Cytokine 
receptor pathway has been found, but is just above our significance threshold (p = 0.0018). 
This interaction involves Cbl, Egfr and several other proteins in the Insulin Signaling pathway, 
including three subunits of PI3K, Crk and Igf1r. Although this interaction was not considered 
significant, it might be biologically relevant given the high differential expression of Cbl and 
Egfr. One possible scenario is that the up-regulation of Cbl is an attempt to compensate for a 
defect in insulin signaling in the HF group, but causes side effects, such as interactions with 
the receptors as listed in the Cytokine receptor pathway.
The switch from glycogen storage to glycogen breakdown observed at t=48 can be expected 
after 48 hour following the glucose challenge. However, the link with the Insulin and Il-6 
signaling pathways is interesting, since the Il-6 signaling pathway has already been linked 
to insulin actions and glycogen metabolism in vitro [27]. Another interesting observation is 
a difference in gene expression between the HF and LF groups in the interactions with the 
Proteasome pathway at t=48, which is possibly related to the TGF-beta pathway. Degradation 
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by the proteasome is an important mechanism in the TGF-beta pathway [28], which may be 
affected in different ways in the HF and LF groups. An identified interaction between the Wnt 
and Insulin signaling pathways might also be related to the observed changes in expression in 
the proteasome pathway, since Gsk3b is involved in degradation of beta-catenin by proteoly-
sis, a process which can be inhibited by Wnt stimulation to stabilize beta-catenin, and which 
subsequently activates transcription of target genes [29]. Inspecting the expression profiles 
of Ctnnb1 and its associated proteasome related genes shows a different expression in the LF 
compared to the HF group at t=48, so this mechanism could be affected by diet in the late re-
sponse to the glucose challenge. Interestingly, one path between the Wnt and Insulin signaling 
pathways is the indirect path between Gsk3b, Sgk3 and Tsc1, which was also observed in the 
comparison between the HF and LF group at t=0. At t=0 the expression of these three genes is 
lower in HF than in LF, but at t=48 the expression is almost equal. This might indicate a com-
mon long term stress response in the HF group that is also triggered in the LF group follow-
ing the glucose challenge. Sgk3 can phosphorylate Gsk3b and may function parallel to AKT 
in PI3K-dependent signaling [30]. Both Akt2 and Pik3c3 show a similar expression profile. 
Pik3c3 encodes for the PI3K class III enzyme, involved in vesicular trafficking [31] and likely 
also in the immune system [32], but the activation mechanisms of PI3K class III enzymes are 
largely unknown.
As illustrated in the analysis described here, the method we developed is especially useful for 
exploring large and complex datasets to find interesting aspects and generate hypotheses. It 
can be used to add an extra dimension to differential gene expression and pathway enrich-
ment results and may complement the search for activated or regulated genes and pathways by 
taking into account how they may interact. It allowed us to explore the NuGO PPS dataset and 
identify relevant gene and protein interactions. It also helped to hypothesize about underly-
ing mechanisms and possible downstream effects of certain groups of differentially regulated 
genes, thereby providing starting points for more focused follow-up studies or experiments.
During the analysis we mainly followed a fixed approach to explore the pathway interactions 
consisting of three main steps. First, we studied the pathway interaction network globally to 
identify highly connected or central pathways and proteins in the network. This, for example, 
pointed us to the apoptosis pathways in the comparison between the two diet groups at t=0, 
which would not have been found by looking at pathway enrichment alone. In the second 
step, we interactively explored the interaction network using Cytoscape and zoomed in to 
specific pathway interactions or subgraphs by visualizing the protein interactions that form 
the paths between the pathways. This step is partly guided by the results of the previous step, 
since neighborhoods of the central pathways or proteins often point to interesting interac-
tions. In addition, we looked for further interactions based on pathways that are known or 
expected to be involved in insulin resistance. For example, this lead us to the interactions 
with the insulin signaling pathways in the late HF response, which were not central in the 
network but appeared to be relevant because of enrichment of all involved pathways and the 
central role of insulin in this analysis. Finally, we often referred back to the original pathway 
diagrams to understand the context of the interacting proteins within the pathway and look 
for any upstream of downstream effects (Figure 2). Together, these steps helped us to better 
understand the generated pathway interaction networks and the biology behind the tran-
scriptomics dataset.
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In addition to the new perspective this analysis provides on the dataset, there are several ad-
vantages that make this method a useful complement to existing pathway analysis techniques. 
Firstly, compared to an analysis limiting to pathway annotations, this combinatory analysis 
integrates additional information by using other sources of protein interactions and allowing 
indirect interactions including proteins that are not annotated to any pathway. This extends 
the coverage of the analysis with an additional 1660 genes that are in the interaction network 
but not annotated to any pathway, of which 929 are available in our transcriptomics dataset. 
This allowed us to move beyond well annotated knowledge in pathways, while still benefiting 
from the framework of canonical pathways and their intuitive visualizations. While the inter-
action network we used here is still relatively small compared to the number of interactions 
we expect to exist, current developments in measuring protein interactions [33] and identify-
ing transcription factor targets [34] will further increase the coverage in the future. Secondly, 
when focusing on enrichment of gene sets or pathways alone, results might be missed since 
pathways may be relevant or activated without being enriched with significantly expressed 
genes, for example in case of post-translational regulation. For example, the three apoptosis 
related pathways identified in this analysis showed little differential expression, however given 
the number of other pathways it connects through via differentially expressed genes might 
indicate they may play a role in the context of this dataset. Finally, since genes and proteins 
often participate in different pathways and may have diverse functions, looking at individual 
pathway diagrams or lists of enriched pathways can be confusing or even misleading. Our 
method provides insight in the multiple roles of a protein in the context of the studied dataset. 
In case a gene is differentially expressed and also interacts with differentially expressed genes 
in multiple pathways, this will typically show up in the pathway interaction network, indicat-
ing that it acts on the verge of different pathways.
Besides several advantages, we also identified several possible improvements that may be 
made to this approach. Firstly, false positive pathway interactions were identified on occa-
sion. One cause can be falsely annotated interactions between proteins in the input interac-
tion network. This is the main reason we already excluded associations based on text-mining 
only from the STRING database, however remaining data may still contain false associations. 
For example, the component of metabolic pathways positioned around the Primary bile acid 
biosynthesis pathway turned out to be a false result after close inspection, due to falsely as-
sociated enzymes in the STRING database. Over time, the quality of interaction resources will 
probably improve, also helped by curation initiatives such as WikiPathways. Another cause of 
false or misleading results is the heterogeneity of many of the pathways. Pathway databases of-
ten include context specific pathways, which provide a summary of processes that are relevant 
to a specific disease or cell type or down-stream signaling of a specific messenger. However, 
the processes included in these pathways are often generic and play a role in other contexts 
as well, so finding an interaction with such a pathway does not automatically mean that its 
context is also relevant to the studied data. For example, we identified several interactions 
with the ESC Pluripotency pathway, which summarizes several signaling cascades regulating 
pluripotency in embryonic stem cells. It is very unlikely that embryonic stem cell function-
ing plays a role in our dataset, but still several interactions with this pathway were identified. 
These turned out to involve only specific parts of the signaling cascades, especially part of 
the Wnt signaling pathway. This is also a common problem in enrichment analysis, and our 
method does not provide a solution yet. Using a set of smallest generic core pathways with as 
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little overlap as possible might lead to cleaner results. Possible alternative sources of pathway 
information that might provide better results than the databases used here could be Gene 
Ontology [35] or Reactome [36], which provide hierarchical gene sets and pathways, allowing 
us to move down in the hierarchy to more specific modules if necessary. However, this would 
require adaptations to the methodology in order to deal with this hierarchical structure. Alto-
gether, these points show that the analysis approach presented here (as well as most currently 
available pathway analysis method) is meant to be used for exploratory analysis and does not 
offer statistical proof for any of the findings. However, in the broader investigation of complex 
data towards more specific questions and testable hypothesis, this method provides a unique 
way to explore the data in a biological context.
The main shortcoming of using only transcriptomics datasets in pathway-based approaches 
is that these provide insight in changes at the mRNA level only. In this study, each identified 
pathway interaction is based on the assumption that if a group of interacting genes is consis-
tently differentially expressed it is likely that changes are reflected at the protein level as well. 
However, this may not always be the case and it is not possible to investigate beyond this 
assumption using such datasets. In addition, a large part of signaling and pathway cross-talk 
probably works at a different level, through protein activation by phosphorylation or other 
post-translational (or post-transcriptional) regulatory mechanisms. If such interactions play 
a role, they cannot be identified with this dataset unless the interaction involves gene expres-
sion changes as well. The interactions that are most relevant to this dataset are transcriptional 
regulation, but unfortunately our interaction network contains relatively few transcription 
factor targets and we were unable to find a resource to increase this number in addition to 
the PAZAR database [37] used in this study. Despite this shortcoming, we were still able to 
show that it allows finding several relevant pathway interactions that help focus follow-up 
experiments.
Although in this particular study we used a transcriptomics dataset only, the method de-
scribed here can directly be applied to other types of data or combinations of different data 
types as well. For example, the interaction network could be extended using the STITCH 
database [38], which defines interactions between chemicals and proteins. Thereby metabo-
lomics data could be incorporated by providing weights for these interactions. In addition, 
some types of data can even be used to define more specific edge weights, depending on what 
action the interaction represents. For example, if protein kinase activity measurements are 
available, this data could be used to obtain more accurate edge weights of specific protein 
interactions that represent activation. This could then even be combined with proteomics 
data to incorporate protein abundance in the edge weights as well and thereby obtaining more 
specific interactions by narrowing down the possible substrates of a protein kinase. Future 
publicly available datasets might cover these types of data at a larger scale and the method 
described here may prove useful in analyzing this complex data at a functional level. To this 
end, all scripts and input data used for this analysis are open-source and freely available (see 
supplementary data).
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Conclusions
We designed an analysis approach to identify interactions between biological pathways in a 
specific context. By applying this method to a transcriptomics dataset, we identified relevant 
pathway interactions and possible key proteins involved in pathway cross-talk in the context 
of insulin resistant mouse liver, and at specific time points following a glucose challenge re-
sponse. In addition, the analysis approach presented here can be applied to different types 
of high-throughput data and will be of more general use to facilitate interpretation of other 
complex datasets.
Methods
Microarray experiment design
The gene expression microarray data from the NuGO Proof of Principle Study 2 [8] was used. 
In this experiment, C57BL/6J mice were fed two different diets for 12 weeks, containing either 
10% (LF) or 45% (HF) fat by energy. Animals fed the HF diet had developed insulin resistance 
by the end of this feeding trial. After 12 weeks, both diet groups were subjected to a glu-
cose tolerance test and liver tissue was removed 0, 0.6, 2 and 48 hours after the glucose chal-
lenge and hybridized to NuGO Affymetrix Mouse GeneChip arrays (NuGO_Mm1a520177). 
The resulting dataset consists of 8 biological replicates per diet and time point (totalling 64 
samples). The data was normalized using the GC-robust multi-array analysis (GCRMA) al-
gorithm [39] and probesets were redefined and annotated to Entrez Gene identifiers using 
the Custom CDF version 11.0.2 [40]. Full details of the experiment and preprocessing of the 
microarrays are described in more detail elsewhere [8,12]. The resulting microarray dataset 
is available from the ArrayExpress repository (http://www.ebi.ac.uk/arrayexpress, accession 
number: E-MTAB-601).
Microarray gene-level statistics
The different groups were statistically compared using the limma R package [41]. To study the 
initial difference between the two diets, before the glucose challenge, we tested for differential 
expression between HF and LF groups at t=0. To study the response to the glucose challenge, 
we tested for differential expression between t=0 and each other time point in the HF and LF 
groups. This resulted in the following statistics:
THF vs LF, t=0: The moderated t-statistic, representing the significance and direction of differential 
expression between the HF and LF group at t=0.
TLF, tx  vs t0: The moderated t-statistic, representing the significance and direction of differential 
expression between each time point after the challenge (t=0.6, t=2 or t=48) and the time point 
just before the challenge (t=0) in the LF group.
THF, tx  vs t0: The moderated t-statistic, representing the significance and direction of differential 
expression between each time point after the challenge (t=0.6, t=2 or t=48) and the time point 
just before the challenge (t=0) in the HF group.
Based on the corresponding p-values as provided by the limma package, q-values were calcu-
lated using the qvalue package [42] to correct for multiple testing. 
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Pathways
Pathways from WikiPathways (analysis collection, v2010-12-07) [10] and KEGG (v2010-06-
14) [11] were used. Pathways categorized under “Human diseases” at the KEGG website were 
excluded from the analysis.
Pathways with high overlap in protein content were merged into a single pathway using a 
step-wise procedure:
1. Calculate overlap between each pathway pair.
2. For each pathway, find other pathways that have >= 75% overlap and merge it with the 
most overlapping pathway.
3. Repeat step 1-2 until no pathway pair with >= 75% overlap is left.
Pathway enrichment
To find pathways that are enriched with genes that score high in the differential expression 
test, the geneSetTest from the limma package was used. This test calculates a test statistic for 
each pathway by taking the mean of the absolute T-statistic of the genes in the pathway and 
calculates P-values by comparing the test statistic to an empirical null distribution based on 
10,000 permutations with random gene sets. The resulting p-value for each pathway repre-
sents the significance of its enrichment with differentially expressed genes, regardless of their 
direction.
Interaction network
The interaction network used in this study combines the following databases:
•	 Protein functional associations from the STRING database (v8.3) [14]. This database 
aggregates interactions from several protein-protein interaction repositories and pathway 
databases. Interactions based on text mining alone and those with a confidence score < 
0.4 were excluded.
•	 Transcription factor targets from the PAZAR database (v2010-08-15) [36].
•	 Manually curated reactions and interactions from the pathways described in the section 
‘pathways’.
These interactions were merged into a single directed network. For interactions without a 
defined direction (e.g. binding), two directed edges in opposite direction were added.
Gene and protein identifier mapping
Genes and proteins were mapped to a common database using the BridgeDb library [43] and 
accompanying synonym databases. All probesets in the transcriptomics dataset and genes 
and proteins in the interaction network were mapped to Ensembl gene identifiers using the 
Mm_Derby_20090720.bridge database. These mapped gene and protein identifiers will be 
referred to as xref in the following description of the algorithm.
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Finding interactions between pathways
To find possible interactions between pathways, we performed the following steps:
1. A graph GPX containing both the xref interactions and pathway-xref associations was cre-
ated. This graph contains two types of nodes, either representing an xref or a pathway. Edges 
were added between the xref nodes based on the interaction network. In addition, each path-
way node was connected to each of the xref nodes that are associated with that pathway.
2. Edge weights were calculated for GPX, based on one of the gene-level statistics described in 
the section ‘Microarray gene-level statistics’. First, a transformation using a sigmoid function 
was applied to the T statistic:
𝑓𝑓(𝑇𝑇) = 1 −  11 + 𝑒𝑒−𝛼𝛼(|𝑇𝑇|−𝜇𝜇) 
This function ensures that the transformed values will range from 0 to 1 and applies a soft 
threshold, where the threshold center is determined by µ and the steepness by α. To transform 
the T statistic, µ=3 and α=2 were used. As result, genes with an absolute T statistic >= 3 (cor-
responding to unadjusted p-value <= 0.004) were emphasized by receiving a lower weight 
(Supplementary figure 16).
Secondly, edge weights were assigned based on the transformed T statistic f(T) of the target 
xref nodes they connect to, or 1 if no data was available for the target xref. If the target of an 
edge was a pathway node, the weight was set to 0.
3. For each pathway node Pn in GPX a subgraph GPn was created containing only nodes that 
could be reached within nb steps form Pn. In this study, parameter nb was set to 5, limiting 
the number of edges between xref nodes in a path to maximal three.
Figure 4: Two examples of overlap between pathways with respect to the algorithm for finding pathway interactions. Red nodes 
are proteins that are present in both pathways, dashed edges will be removed before finding shortest paths. A: A pathway pair with 
one overlapping protein (protein A) which connects to distinct paths within the two pathways. The overlap itself is not counted as 
interaction between the pathways, but by removing only the dashed edge A still acts as an indirect intermediate to establish a path 
between P1 and P2 via proteins B and E. B: A pathway pair which shares two proteins that do not connect to distinct paths within 
each pathway. In this case these proteins do not contribute to the pathway interaction, because the dashed edges are removed.
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4. For each pathway node Pm in GPn another subgraph was created containing nodes Pn, Pm, 
the direct neighbors of Pn and Pm (the xrefs in these pathways) and all xref nodes that are not 
direct neighbors of a pathway node (xrefs that are not in any pathway). Excluding xref nodes 
that are present in pathways other than Pm and Pn is necessary to prevent detection of false 
interactions between Pn and Pm that cross other pathways. Such an interaction should not 
be represented as direct interaction between Pn and Pm, but rather as two interactions with 
the other pathway as intermediate between Pn and Pm. For xref nodes that were connected 
to both Pn and Pm, the edge to Pm was removed to prevent paths to go directly through an 
overlapping xref (Figure 4).
5. The shortest path between Pn and Pm in GPn was found, taking into account the edge 
weights (the length of a path is the sum of its edge weights). The path length was stored and 
the edges of the path, except those that connect Pn or Pm, were deleted from GPn (Figure 1C).
6. Step 5 was repeated until a preset maximum path length lmax was reached (Figure 1C). In 
this study, lmax was set to 0.9, ensuring that paths between xrefs with low significance or no 
measured data (which will have a weight close to 1, see step 2) do not contribute to the inter-
action score.
7. For each pathway pair PnPm a list of path lengths li is now available. These were converted 
to a single interaction score SPnPm for each pathway pair by calculating the sum of the inverted 
lengths:
𝑆𝑆𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 = � 1𝑙𝑙𝑖𝑖𝑖𝑖  
8. Significance of the interaction was calculated by comparing the interaction score to an 
empirical null distribution. This null distribution was generated by repeating step 3-7 to re-
calculate an interaction score between Pn and Pr (a randomized version of Pm), resulting in a 
collection of randomized interaction scores SPnPr. For each permutation, Pr was generated by 
reconnecting the endpoints of its adjacent edges (which are the nodes representing the xrefs 
associated to the pathway) to different xref nodes from the interaction network that have a 
similar strength (also weighted degree [44]) as the original xref node. This way, the random-
ized pathway has a connectivity that is similar to the original pathway. Empirical p-values 
were calculated for each pathway pair by counting the number of times SPnPr is higher or equal 
to SPnPm and dividing this by the number of permutations. Firstly, p-values for each pathway 
pair were calculated using 100 permutations. Secondly, the resolution of the p-value of poten-
tially significant pathway pairs was increased by adding another 1000 permutations for pairs 
that had a p-value < 0.1 after 100 permutations.
This algorithm was implemented in the statistical language R [45] and uses the igraph pack-
age [46] for handling graph structures and finding shortest paths between two nodes. The R 
source code and utility scripts to generate and format the data are available at http://code.
google.com/p/tkelder/wiki/PathwayInteractions.
Parameter nb limits the maximum allowed number of edges in a path, which significantly 
reduces the calculation time. This also filters out paths with many edges that are less likely to 
be biologically relevant, even though their weighted path length might be low.
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To reduce the contribution of overlapping proteins between pathways to the interactions be-
tween pathways, the edge from an overlapping protein to one of the pathways in a pair is 
removed in step 4. While pathways with more than 75% overlap were merged, some pathways 
might still have much overlap that may outweigh the influence of pathway interactions via 
protein interactions. However, to completely discard overlapping genes might be too conser-
vative, since an overlapping protein may be a key regulator that might connect two distinct 
parts of the different pathways. For example, in Figure 4A, two pathways both contain protein 
A, which connects to a distinct path in each pathway. If protein A would be excluded from 
the analysis (as in Li et al. [6]), a relevant interaction between the two distinct paths will be 
missed. However, in Figure 4B, two pathways share a complete path of three proteins which 
does not connect to any other distinct part within each pathway and hence these proteins are 
unlikely to contribute to an interaction between the pathways. In this case, our approach of 
removing one of the edges with the pathway will give equal results as excluding the proteins.
Network analysis and visualization
All networks were visualized using Cytoscape [13]. Network properties such as average path 
length, clustering coefficient, node degree and betweenness centrality were calculated using 
the igraph library in R. Betweenness centrality as displayed in Supplementary figure 3 was 
normalized by dividing the value calculated with the igraph function betweenness by the max-
imum centrality, which is the total number of node pairs in the network, excluding the node 
for which the betweenness centrality is calculated.
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Integration of existing knowledge in exploratory data analysis is an important step to make 
optimal use of the current possibilities to generate large datasets in biology research and to 
understand the underlying biology. This thesis aims to improve this step by utilizing the con-
cept of biological pathways. In chapter 2 several hallmarks of the exploratory data analysis 
paradigm were applied to biological pathways and chapters 3 and 4 presented two bioinfor-
matics tools that were designed to enhance the ability to include pathways in exploratory data 
analysis. Chapter 5 describes an application of an exploratory analysis using the developed re-
sources integrated with additional public data. This chapter will evaluate the developed tools 
in context of the key aspects of exploratory data analysis.
Maintaining a collection of pathways
One of the prerequisites for effectively utilizing biological pathways in a data analysis is the 
availability of an open repository of digitalized pathways that can be applied to bioinformatics 
approaches. Curating and maintaining a public collection of pathways is a large and never-
ending task, as a continuous stream of new knowledge is being generated. Given the cur-
rent exponential growth of knowledge, centralized curation as employed in existing pathway 
resources does not scale [1]. The WikiPathways database described in this thesis provides 
an original approach to maintaining a pathway collection. It offers a free and open pathway 
repository in the form of a wiki that makes it possible for any researcher to take on the task of 
curating the content. WikiPathways and the wiki approach applied to curation of biological 
information in general, received positive attention in commentaries in several widely read 
scientific journals [2-6], indicating that the research community is open to novel solutions 
towards more scalable curation.
Wikis provide an effective platform for community-based curation. Users can directly con-
tribute, update and correct the content, which in the long term improves comprehensiveness 
and quality. The mechanism behind this can be described as a positive feedback loop [7]. The 
wiki starts with some initial content which attracts users. A small fraction of these users will 
also correct or extend the content, which on average leads to an improvement of the quality 
and usefulness of the content. This will attract more users, thereby also increasing the number 
of potential editors, which improves the content even more. An example of how this mecha-
nism has worked very well is Wikipedia, which has lead to a comprehensive encyclopedia that 
compares in quality to more established, centrally curated alternatives [8]. Based on statistics 
gathered during the short history of WikiPathways, it might be possible to obtain more in-
sight in how well the wiki approach has worked so far for biological pathways.
If a relation would exist between usage and contribution in WikiPathways, the number of 
edits to a pathway is expected to increase with the number of views. Indeed, pathways that 
have many views are also among the ones with the most edits and have been edited by a larger 
group of authors (Figure 1). Following the positive feedback mechanism, usage would also 
result in a growth of content. Since the number of site visits has increased from over 1100 
per month over the three months prior to publication to almost 5400 per month over the last 
three months of 2010, a growth and improvement of content would also be expected. Indeed, 
compared to the initial content of WikiPathways, the number of human pathways has grown 
with 128% and the number of annotated human genes in these pathways has increased with 
30% (Figure 2). To put this number in perspective, the pathway collection for GenMAPP, on 
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Figure 1: Relation between views and edits for the pathways at WikiPathways. Each dot represents a pathway, the x-axis represents 
the number of times the pathway has been viewed and the y-axis represents the number of times the pathway has been edited. The 
color and shape of each dot indicates the number of unique users that edited the pathway.
Figure 2: Two indicators of WikiPathways growth over the period 2008-2010 for human specific content. The red line and left axis 
represents the number of human pathways. The blue line and right axis represents the number of unique human genes across all 
pathways.
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which the initial WikiPathways content was based, grew with only 1% in number of pathways 
and 5% in number of genes in the three years preceding WikiPathways [9]. In addition, since 
the number of pathways in KEGG, a comparable, but centrally curated resource, has grown 
with 14% in the same period, the community-based curation mechanism seems quite effec-
tive.
In addition to the usage and content growth of WikiPathways, the size and activity of its com-
munity have also grown. In 2008, on average 10 users per month made one or more edits to 
a pathway and 87 edits were made per month. These numbers have grown to on average 16 
editing users and 261 edits per month over 2010, a growth of 56% and 200% respectively. Al-
though the active community shows growth, it remains relatively small, probably too small to 
effectively keep up with the growth of biological knowledge that can be captured in pathways. 
The size and activity of the community can be improved in two main ways that reinforce each 
other. Firstly, the part of users that become contributor can be improved to increase the activ-
ity of the community. Secondly, improving usability of the pathways will increase the size of 
the community, since the number of users is proportional to utility of the content.
The barrier to contribute seems fairly high, since on average only 0.36% of the website visi-
tors actually edited a pathway one or more times. However, compared to Wikipedia, a wiki 
with a very active community, the barrier is not that high. For the English Wikipedia, only 
0.02-0.03% of the visitors is active contributor (defined as at least 5 edits in a given month 
[10]) and for WikiPathways this translates to almost 0.19% averaged over 2010. However, in 
contrast to Wikipedia, the content at WikiPathways is focused on a smaller domain and a 
large part of the target audience is expert in this domain. Therefore, it will probably be worth 
trying to lower this barrier even further. One improvement could be on speed, stability and 
user-friendliness of the editor. To optimally re-use code and programming efforts, the current 
editor is running on Java applet technology and directly based on the stand-alone application 
PathVisio [11]. This causes long load times, lacks integration with the browser, and requires 
Java to be installed and properly configured for the web browser. A better solution would be 
to implement an editor as a pure web application which is fully integrated in the webpage that 
displays the pathway. This way, the editor as separate entity will disappear and each part of the 
page will be directly editable, improving the consistency of the user interface and decreasing 
load times. The new HTML5 standard [12] that is currently being adopted by most browsers 
may provide the right platform.
Another way to lower the barrier is to assist and challenge users to contribute by pointing out 
which parts of the content are in need for improvement. For example, some potential errors, 
such as wrong or missing gene annotations, can be detected automatically and presented to 
the user. Several automated scripts called ‘bots’ have already been implemented to find such 
errors and put a banner on the pathway page providing instructions on how to fix them. Such 
corrections are generally straightforward, take relatively little time and may therefore lower 
the barrier for new contributors. Another approach, taken by the TFe wiki project [13], could 
be to add a clear indicator of completeness of the content. This assigns a completion percent-
age to each page and lists steps that can be taken to increase this score. For pathways, such a 
score could be based on basic parts such as a textual description, categorization or reference 
to literature. Again, this approach could encourage users to contribute by splitting up the 
curation into small, manageable tasks. Finally, an approach taken by Gene Wiki project [7] 
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to improve curation of gene articles at Wikipedia is the automatic creation of initial pages, 
called ‘stubs’. These pages are typically based on content that is automatically extracted from 
authoritative sources and provide an initial starting content. Since the barrier for starting a 
completely new article is usually higher than extending an existing article, this greatly in-
creased the number of contributors [14]. This approach will be harder to apply to pathways, 
since in contrast to genes, there is no complete list of possible pathways. One option might be 
to find proteins that are not annotated in any pathway, but do occur with a high frequency sci-
entific publications, indicating that they represent relevant knowledge yet to be translated into 
a pathway. Small pathway stubs could then be generated for these proteins by for example in-
cluding potential interacting proteins from sources such as STRING [15] or GeneMania [16]. 
Although these will probably not reflect a proper pathway and contain false positive or non-
relevant interactions, this might challenge and engage users to correct or extend these stubs.
Since the release of WikiPathways, several use cases have emerged that illustrate the utility 
of pathway content at WikiPathways. Defining these use cases and providing tools to sup-
port them might help to attract new users and grow the active WikiPathways community. 
WikiPathways has mainly been used as resource, publishing tool, collaborative editor and 
educational tool. The following sections will highlight examples of these use-cases and point-
ers to improve them.
WikiPathways as resource
WikiPathways can be used as resource for researchers in two ways. Firstly, the website pro-
vides a reference for biological knowledge. Each pathway page provides a useful starting point 
to lookup knowledge on a specific biological mechanism, including the pathway diagram, 
hyperlinks to detailed information about genes, proteins and metabolites, and relevant lit-
erature references. Website statistics indicate that WikiPathways is indeed being used this 
way, since over 40% of the visits originated from Google searches on keywords related to 
biology, and the currently most visited pathway (One Carbon Metabolism [17]) has been 
visited over 11,000 times. Secondly, WikiPathways can be used as repository for pathways for 
bioinformatics research and exploratory data analysis. Pathway archives can be downloaded 
in computable formats and are also distributed with tools such as GenMAPP [18] and Path-
Visio [11]. With these tools, researchers can perform overrepresentation analysis to prioritize 
biological pathways based on the data and visualize the data on pathway diagrams. This ap-
proach has been taken in several studies [19-21], including two studies where I participated 
as bioinformatics researcher in the exploratory data analysis phase [22,23]. In addition to 
tools that bundle WikiPathways content, the web service as described in chapter 4 provides a 
resource of pathway information via a programmatic interface, allowing integration in tools 
and scripts. This web service processed over 45,000 requests per month over 2010, exclud-
ing requests from maintenance scripts, indicating that WikiPathways is also being used as 
resource for bioinformatics research.
A common concern about wikis is the difficulty to ensure quality and accuracy of the content, 
because of the lack of an appointed group of expert curators. Therefore providing tools to 
get background information on the quality of the content may make it more attractive and 
convince skeptical users to use WikiPathways as a resource. A mechanism that has been very 
effective so far is organization of the content into several quality levels via revision specific 
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tagging of pathways. Currently, the two main quality levels are featured pathways and analysis 
collection pathways, where the latter may be less well curated and visually appealing, but do 
have properly annotated genes and proteins thereby being useful for analysis. Download ar-
chives provide snapshots of a subset of pathways and specific revisions that correspond to the 
quality level. While these quality levels apply to whole pathways, a more sophisticated method 
would be to provide levels of accuracy on specific parts of the pathway. Algorithms to derive 
this information have already been implemented to process textual content for Wikipedia by 
WikiTrust [24] and for WikiGenes [25]. Both approaches are based on tracking text origin 
and author information, making it is possible to trace back each part of the text to the original 
author and revision and thereby providing a tool to judge quality of the content. WikiTrust 
also uses this mechanism to provide a trust score for each part of the text, based on the as-
sumption that content which is stable over different revisions is more trustworthy than con-
tent that undergoes many changes. It also includes author reputation based on the content of 
the wiki, which increases when the author’s contributions are preserved and decreases when 
they are reverted. It might be possible to adapt this algorithm to work with pathways. Being 
able to find the origin, authors and revision history of a specific interaction or protein will be 
a powerful tool to judge trustworthiness of pathway information in analyses. For example, in 
the analysis described in chapter 5 of this thesis, a trust score for interactions could be inte-
grated in the edge weights to reduce false positive results.
WikiPathways as publishing tool
Pathway diagrams are widely used in scientific publications as figures accompanying the text. 
These figures are being translated into annotated pathways in digital form, however this is a 
rather tedious and often error prone task. Using WikiPathways, authors could directly create 
a properly annotated pathway and either save it as image to include in a publication or pro-
vide it as supplementary material. Several authors have already taken this approach [26,27], 
which offers additional advantages from the author’s point of view. Firstly, the pathway page 
at WikiPathways improves the reader experience, by providing links to additional detailed in-
formation and unambiguously annotated genes, proteins and metabolites. In contrast, when 
using a static image, manual searching is required to find more information about a protein 
on the diagram and ambiguous protein names may lead to incorrect interpretations. Sec-
ondly, the online pathway improves visibility and usability of the author’s results, by making it 
searchable via internet search engines such as Google and redistributing it with several bioin-
formatics tools for use in data analyses of other researchers. When such analyses lead to new 
publications, the original source of the pathway can be tracked and cited, thereby increasing 
its measurable impact. Finally, once at WikiPathways the pathway can be updated by both the 
original author and community based on new research results that may become available over 
time to provide a better representation of the biological mechanism.
The usability of WikiPathways as publishing tool has recently been improved by implement-
ing the possibility to temporarily hide a pathway from public view. Thereby authors can re-
trieve a stable identifier that can be used to reference the pathway from the manuscript and 
allow reviewers to inspect the pathway, without giving away their results before publication. 
Another way to support publication better is to allow more advanced graphical styles in the 
pathway diagrams. Currently, the style used in WikiPathways is focused on data analysis and 
very minimal to support data visualization, while the typical style in publications is more 
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colorful and contains more complex illustrations to clarify mechanisms of action. Although 
the GPML format is internally very flexible and allows creation of complex graphics, drawing 
these is not straightforward in the editor. WikiPathways might be able to reach a wider audi-
ence if the editor would provide more control over curved paths, allow inclusion of custom 
graphics or provide a set of templates that match styles commonly used in publication better.
WikiPathways as collaborative editor
WikiPathways can be used by a group of researchers to build and maintain a set of focused 
pathways supporting ongoing projects or research collaborations. For example, the Micro-
nutrient Genomics project [28] aims to provide a resource for knowledge on the biological 
context of micronutrients and uses WikiPathways to collaboratively edit a subset of pathways 
related to these topics. A core team of experts builds pathways and streamlines contributions 
from the community. Along the same lines, the California Institute for Regenerative Medicine 
(CIRM) has adopted WikiPathways to highlight a subset of pathways contributed by the stem 
cell research community. For initiatives like these, WikiPathways provides the option to create 
a portal page, which provides an access point to the subset of pathways and can be customized 
with the project logo and announcements. Such portals make the content more attractive for 
a specific group of users because it provides a more convenient entry point that is focused on 
their research subject.
Another way WikiPathways can be used as a collaborative editor is by providing a frame-
work for collecting community contributions for centrally curated databases. In this setup, 
the content of the database is mirrored on WikiPathways which provides a medium for its 
users to contribute corrections or additions. This way, WikiPathways complements centrally 
curated databases by providing a staging ground for new content that can then be reviewed 
by appointed curators for inclusion in the database. The Reactome database is currently in 
the process of setting up this workflow using WikiPathways to improve their ability to col-
lect community contributions [29]. A similar approach is taken by the maintainers of the 
PluriNetwork [30], an electronic resource for curated protein interactions relevant to pluri-
potency, for which a version is maintained at WikiPathays that allows users to contribute new 
interactions. Partnering with other pathway or interaction resources directly increases the 
community and contribution rate of WikiPathways. In addition, it increases database inter-
compatibility and makes each contribution from the community more valuable, because it 
will eventually be distributed over different pathway resources.
WikiPathways in education
Building a pathway diagram from existing knowledge is a good educational exercise and 
works well in combination with already existing literature research projects for undergradu-
ate students. By creating a pathway, students learn about the biology and become familiar 
with bioinformatics tools and resources, which are important for analyzing experimental 
data in their future research career. WikiPathways has been used for educational projects 
and courses at Maastricht University at a small scale. Several pathways at WikiPathways are 
direct results of undergraduate projects [31,32] where a student performed an extensive lit-
erature review about a specialized topic. Other pathways resulted from shorter teaching ses-
sions where multiple students worked on a single pathway [33,34]. Recently, the EcoliWiki 
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project has adapted the education model at a larger scale, introducing a competition-based 
element that comes closer to the community curation model [35]. In this project, students 
contribute content to the wiki, but are also stimulated to correct the contributions of their 
fellow students. This directly benefits motivation of the students and improves quality of the 
contributions. In addition, exposing students to the principles of a wiki helps cultivating a 
future research community that is better prepared for an open-data culture and new ways of 
sharing and curating knowledge.
Altogether, the website statistics and the four use cases discussed here, indicate that WikiPa-
thways is being adapted by the research community as a versatile tool. Eventually, both usage 
and contribution need to reach a critical mass to establish a stable active community that can 
keep up with the continuously growing amount of knowledge and publications. As each of 
the different use cases develops further and new ways of using the content emerge, it is likely 
that the community will continue to grow and contributions will increase. The open nature of 
the WikiPathways project (both in content, code and collaborations) allows any user group to 
adapt and implement features to support a specific use case, and stimulates new communities 
to adapt WikiPathways for their research. In the end, this will lead to a better representation 
of our knowledge as biological pathways, and contribute to improving exploratory pathway 
analysis.
Integration of pathways in bioinformatics tools and workflows
To effectively utilize pathway content in exploratory data analysis it should be possible to 
integrate it into bioinformatics tools, scripts, workflows and to combine it with other types 
of information and data. The web service described in chapter 4 provides an infrastructure 
for programmatic access to WikiPathways content. In addition to its utility in assisting cura-
tion tasks (the Reactome workflow and the bots as discussed before are both supported by 
the web service), the web service was also used for integration of pathway information in 
external applications. Several online resources and databases integrate pathway information 
from WikiPathways, including NCBI BioSystems [36], BioPortal [37] and CitedIn [38]. NCBI 
BioSystems integrates different pathway resources with the Entrez database. This allows re-
searchers to directly view pathway annotations at different NCBI resources, for example a 
gene page at Entrez Gene or a compound page at PubChem. The CitedIn website provides 
a novel measure of research impact based on internet citations and uses WikiPathways as a 
citation resource, by querying literature references from pathways via the web service. Bio-
Portal is a resource that integrates and annotates various ontologies which organize concepts 
in topics such as taxonomy, tissues or diseases. It uses WikiPathways to derive functional 
annotations for ontology terms. These examples demonstrate how the WikiPathways web ser-
vice supports online resources in extracting different types of information from pathways to 
enrich their content.
Another use case that directly benefits exploratory pathway analysis is the integration into 
bioinformatics tools and workflows. An example of a web application that uses the WikiPa-
thways web service for pathway analysis is WebGestalt [39], which allows researchers to find 
out which pathways are overrepresented with genes from a user-specified input list, such as 
a list of differentially expressed genes. This web application uses WikiPathways as one of the 
pathway resources and uses the built-in visualization method of the web service to directly 
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visualize the results on a pathway diagram in the web browser. An example of an offline tool 
that integrates WikiPathways content via the web service is DomainGraph [40]. Domain-
Graph is implemented as a plugin for the widely used network analysis tool Cytoscape [41] 
and can be used to visualize alternative-splicing data. To help finding possible functional ef-
fects of alternative splicing it links the data to biological pathways and directly visualizes it on 
pathway diagrams from WikiPathways. These examples show that the web service improves 
integration of pathways in different specialized analysis tools.
The WikiPathways web service is only part of a bigger trend of making data available through 
web services [42]. This will significantly enhance exploratory data analysis by improving uni-
fied data access from different tools and facilitating integration of different resources in an 
analysis workflow. For example, Cytoscape already provides a set of web service clients to im-
port and integrate data from different resources, including the WikiPathways. This allows tool 
developers to focus on the core features of a new analysis method and minimize time spent 
on implementing data import features. For example, the ExprEssence plugin for Cytoscape 
[43] only implements new analysis features and uses the functionality of the already existing 
web service clients to support different pathway resources including WikiPathways. Design 
choices that utilize web services also improve homogeneity of data import procedures from a 
user perspective, increasing the user friendliness of a tool and minimizing the need to manu-
ally download data and convert between different data formats.
Exploratory analysis to find interactions between pathways
A hallmark of exploratory data analysis is to reformat and present the data in different ways 
to provide new perspectives that allow different observations which together help developing 
vague questions and ideas into more focused and testable hypotheses. The analysis described 
in chapter 5 presents a new pathway-centered perspective on the data that complements ex-
isting methods such as enrichment analysis. By finding regulated paths between pathways, it 
shows the dataset from a higher perspective, showing how functional modules might interact, 
cooperate and regulate each other to generate a complex phenotype. Zooming in to the pro-
tein interactions composing these paths also provides possible mechanisms for pathway in-
teractions at a more detailed level. This has led to several interesting observations about acti-
vated mechanisms of pathway cross-talk. It also made it possible to identify relevant pathways 
that were not enriched with differentially expressed genes, but did contain many regulated 
paths between other pathways. By limiting to established analysis techniques such as enrich-
ment analysis, these aspects of the data would most likely not have been observed. Although 
this analysis approach alone did not lead to a full understanding of the data, when combined 
with methods that provide different perspectives it might be possible to gather enough pieces 
of the puzzle to better explain the complex biology underlying the dataset.
From a developer point of view, the analysis described in chapter 5 demonstrates the im-
portance of flexibility and reusability of available tools and methods. Firstly, this approach 
combines several different types of information, including pathways and interactions from 
different resources. Importing and mapping identifiers was achieved with minimal script-
ing, because the bulk of the work had already been implemented by the BridgeDb [44] and 
PathVisio [11] libraries. Furthermore, graph algorithms and visualization tools were read-
ily available from packages such as igraph [45] and Cytoscape. Therefore, the overhead of 
76
implementing functionality secondary to the core analysis method could be kept to a mini-
mum. Secondly, the analysis method itself has grown out of a simpler visualization method 
that was implemented ad-hoc during preceding data analyses [22,46], which was only feasible 
because the main parts were already available as open-source libraries and tools. Based on 
these preliminary results, a decision could be made whether to develop it further into a more 
sophisticated analysis method. Since the source code of the analysis method itself is publicly 
available, it can be developed further into a more generic tool or library once its usefulness 
has been demonstrated. This shows an interesting cycle of developing new analysis methods 
into generic tools that is being fueled by making analysis scripts, source-code and program-
ming libraries publicly available.
Conclusion
This thesis covered merely a fraction of the current developments towards better exploratory 
data analysis methods in the context of biological pathways. Pathway based approaches for 
data analysis and visualization continue to mature and become more established and stan-
dardized. This work contributed to this process by providing a platform for maintaining path-
way information, an infrastructure to use it computationally and by demonstrating how these 
flexible tools and resources can be used to push the boundaries of pathway analysis. Our abil-
ity to measure biological phenomena in more detail and higher quantities keeps improving 
and the computational power to process and integrate this data continues to grow. However, 
interpretation largely remains a human task. By providing an interface between computer and 
human, the role of biological pathways in the process of exploring and understanding this 
data becomes increasingly important.
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Een belangrijk doel van biologisch onderzoek is om beter te begrijpen hoe interacties tussen 
verschillende moleculen het functioneren en disfunctioneren van organismen bepalen. Deze 
mechanismen zijn vaak zeer complex. Ter illustratie: Het humane DNA bestaat uit ongeveer 
drie miljard base paren die coderen voor meer dan negenentwintig duizend eiwitten. Deze 
eiwitten komen voor in verschillende hoeveelheden en varianten, die afhankelijk zijn van 
omgevingsfactoren, cellulaire locatie en onderlinge interacties.
Er is al veel bekend over deze interacties en mechanismen in de context van verschillende 
organismen en ziekten. Een veelgebruikte manier om deze kennis weer te geven is het concept 
biologisch pathway. Een typisch pathway beschrijft een set moleculaire entiteiten (e.g. genen, 
eiwitten of metabolieten), hun onderlinge relaties of interacties, en variaties in tijd of locatie. 
De verschillende stappen in een pathway worden vaak op een grafische manier weergegeven 
in de vorm van een diagram. In een pathway wordt onze kennis over de moleculaire biologie 
op een functioneel niveau beschreven en georganiseerd. Over de jaren is er een canon 
van pathways ontstaan die de werking van veel voorkomende biologische mechanismen 
samenvatten.
Dankzij de ontwikkeling van nieuwe technieken is het de laatste decennia mogelijk geworden 
om relatief gemakkelijk grote hoeveelheden experimentele data te genereren. De zogenoemde 
‘high-throughput’ of ‘omics’ technieken stellen biologen in staat om metingen te doen op 
duizenden entiteiten binnen een enkel experiment. Hierdoor kan bijvoorbeeld de expressie 
van alle genen of de aanwezigheid van vele eiwitten tegelijk gemeten worden. Door deze 
metingen uit te voeren op verschillende tijdstippen, of door het vergelijken van verschillende 
cel typen, kan bepaald worden welke veranderingen er optreden op moleculair niveau. Door 
het grote bereik maar relatief hoge ruis in dit type experimenten zijn deze uitermate geschikt 
voor exploratieve analyse. Dit soort analyse heeft als doel om gerichte vragen en hypothesen 
te genereren die vervolgens getest kunnen worden in meer gerichte experimenten.
De hoeveelheden experimentele data zijn zo groot dat ze niet meer efficiënt met de hand 
geanalyseerd kunnen worden. Daarom worden er binnen de bioinformatica algoritmen en 
computer software ontworpen en toegepast om het interpreteren van deze data mogelijk te 
maken. Een belangrijke stap in een analyse is het combineren van de data met de kennis die 
we al hebben, om zo tot nieuwe biologische inzichten te komen. Dit proefschrift focust op dat 
deel van de analyse, waarbij pathways worden gebruikt om bestaande kennis te integreren 
met bioinformatica toepassingen.
Het doel van dit proefschrift is om exploratieve data analyse te verbeteren door het gebruiken 
van biologische pathways. Hoofdstuk 2 bevat een korte samenvatting van bestaande pathway 
analyse technieken. Twee veelgebruikte toepassingen zijn het visualiseren van data op 
pathway diagrammen en het uitvoeren van over-representatie analyse, waarbij wordt gezocht 
naar pathways die waarschijnlijk betrokken zijn in het bestudeerde biologische mechanisme. 
Verder zijn een aantal kenmerken en vereisten van exploratieve data analyse beschreven, 
die verder in het proefschrift worden gebruikt om analyse methoden te verbeteren en toe te 
passen.
Een van de vereisten om pathways te kunnen gebruiken in data analyse is dat onze huidige kennis 
over moleculaire biologie wordt gerepresenteerd als pathways. Het verzamelen van biologische 
pathways is een immense taak, omdat deze niet automatisch kunnen worden gegenereerd, 
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maar handmatig moeten worden gecompileerd uit kennis verspreid over wetenschappelijke 
literatuur en verschillende domein experts. De pathway database WikiPathways die is 
beschreven in hoofdstuk 3 is een unieke benadering om deze grote hoeveelheden biologische 
kennis te verzamelen in een vorm die gebruikt kan worden in bioinformatica toepassingen. 
WikiPathways is een wiki waarbij, zoals op Wikipedia, alle informatie direct te bewerken is 
door gebruikers. Dit geeft de wetenschappelijke gemeenschap zelf controle om de informatie 
te verbeteren in plaats van dit aan een kleine groep curators over te laten. Hiermee biedt 
WikiPathways op termijn een beter schaalbare oplossing om de exponentiële groei van 
nieuwe kennis aan te kunnen. Een vereiste hiervoor is wel dat het aantal actieve gebruikers 
groot genoeg is om een goede kwaliteit en actuele inhoud te verkrijgen. Twee voorbeelden van 
punten die dit moeten bevorderen zijn een directe bruikbaarheid van de pathway informatie 
in onderzoek en een laagdrempelige interface om pathway informatie in te voeren in de vorm 
van een intuïtief werkend tekenprogramma. Gezien het kort bestaan van WikiPathways is het 
moeilijk te zeggen of een gebruikersgroep van voldoende grootte bereikt kan worden, echter 
zowel de inhoud als het aantal actieve gebruikers laten een positieve groei zien.
In hoofdstuk 4 wordt een webservice beschreven die het mogelijk maakt effectiever 
gebruik te maken van pathway informatie in exploratieve data analyse. Deze webservice 
geeft computerprogramma’s direct toegang tot de informatie op WikiPathways. Dit heeft 
diverse toepassingen. Ten eerste wordt het hierdoor mogelijk om pathways te integreren 
in verschillende bioinformatica software. Zo is het bijvoorbeeld mogelijk om vanuit het 
netwerk visualisatie programma Cytoscape direct de nieuwste versie van een pathway 
op WikiPathways te in laden. Ook geeft het de mogelijkheid om bijvoorbeeld op de NCBI 
website informatie over een specifiek gen uit te breiden met de verschillende pathways 
waarin het een rol speelt. Ten tweede maakt de webservice het ook makkelijker de pathways 
direct te integreren in een analyse script of workflow en eventueel te combineren met andere 
typen informatie of publieke datasets die ook via webservices beschikbaar zijn. Als laatste 
maakt de webservice het ook mogelijk om curatie taken op WikiPathways te assisteren. Zo 
draaien er bijvoorbeeld voortdurend computerprogramma’s op de achtergrond die bijdragen 
van gebruikers controleren op veel voorkomende fouten en deze terugrapporteren zodat ze 
verbetert kunnen worden.
Hoofdstuk 5 geeft een voorbeeld van een exploratieve data analyse die is opgebouwd rondom 
pathway informatie. Het doel van deze analyse is om inzicht te krijgen in mogelijke interacties 
tussen pathways in de context van insuline resistentie. Zoals veel complexe ziekten spelen bij 
insuline resistentie waarschijnlijk verschillende pathways een rol en is het dus nuttig om te 
kijken naar het samenspel tussen pathways. Veel bestaande pathway gebaseerde methoden 
gebruiken pathways als geïsoleerde entiteiten, dus biedt deze analyse een nieuw perspectief 
op de data. De analyse gaat uit van een gen expressie dataset gemeten in lever weefsel van 
gezonde en insuline resistente muizen, voorafgaand aan en op verschillende tijdspunten 
na het uitvoeren van een glucose tolerantie test. Op basis van een netwerk met interacties 
tussen genen en hun eiwit producten wordt tussen elk paar pathways een set kortste paden 
gezocht waarbij de lengte van een pad de som is van de gewichten van de verbindende eiwit 
interacties. Interacties tussen eiwitten waarvan de coderende genen differentieel tot expressie 
komen krijgen een lager gewicht toegewezen, waardoor paden met veel veranderde genen 
een kortere lengte krijgen. Op basis van de aanname dat hoe meer en kortere paden tussen 
twee pathways gevonden worden, hoe waarschijnlijker het is dat deze pathways een interactie 
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aangaan, kan dan een netwerk van pathway interacties worden afgeleid. Op deze manier zijn 
diverse mogelijke pathway interacties gevonden voor verschillende vergelijkingen van de gen 
expressie tussen gezonde en insuline resistente groepen en tussen de verschillende tijdspunten. 
Bovendien is er ingezoomd op de onderliggende eiwit interacties om mogelijke mechanismen 
en eiwitten die betrokken zijn bij communicatie tussen pathways te bestuderen. Dit heeft 
tot nieuwe inzichten en hypotheses geleid over het mogelijk samenspel tussen verschillende 
pathways in insuline resistentie en hoe deze verandert als gevolg van een glucose stimulans.
Tezamen heeft het onderzoek zoals beschreven in dit proefschrift op een aantal punten 
bijgedragen aan de verbetering van exploratieve data analyse met behulp van biologische 
pathways. Er is een platform gecreëerd voor het verzamelen en verbeteren van pathway 
informatie die geschikt is voor gebruik in bioinformatica toepassingen. Er is een infrastructuur 
gebouwd om deze informatie programmatisch toegankelijk te maken en te integreren in 
analyses. Tot slot is gedemonstreerd hoe de ontwikkelde hulpmiddelen rondom pathway 
informatie gebruikt kunnen worden om originele analyse methoden te ontwikkelen die 
nieuwe perspectieven bieden op een bestaande dataset.
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